Haemonetics Corporation
(NYSE:HAE)

Haemonetics Corporation, a healthcare company, provides hematology products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis e...

Website: http://www.haemonetics.com

Founded: 1971

Full Time Employees: 3,004

Sector: Healthcare

Industry: Medical Instruments & Supplies

Share this website to your friends

• Market Cap:

• Exchange:

• Shs Outstanding:

• Employees:

• Beta:

• Return on Equity (ROE) ttm:

• Return on Assets (ROA) ttm:

• EPS ttm:

• Book value per Share:

• Cash per Share:

• Current ast per Share:

• P/E ttm:

• P/E forward:

• P/E ttm high:

• P/E ttm low:

• P/S ttm:

• P/B ttm:

• P/FCF ttm:

• PEG ratio:

• Cash Ratio ttm:

• Quick Ratio ttm:

• Current Ratio ttm:

• Gross Mgn ttm:

• EBITDA Mgn ttm:

• Operating Mgn ttm:

• Net Income Mgn ttm:

• Trailing Div yield:

• Forward Div yield:

• Payout Ratio ttm:

• Ex-Dividend date:

• Target Price High:

• Target Price Low:

• Target Price Mean:

• Number of Analysts:

• Debt Ratio ttm:

• Debt to Equity ttm:

• Total Net Debt:

At a glance:

Bull Thesis:

Bear Thesis:

Main Competitors:

Moat:

Income Statements:

Quarterly

Annual

Unit: USD	2026-03-28	2025-12-27	2025-09-27	2025-06-28	2025-03-29	2024-12-28	2024-09-28	2024-06-29	2024-03-30	2023-12-30	2023-09-30	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2022-01-01	2021-10-02	2021-07-03	2021-04-03	2020-12-26	2020-09-26	2020-06-27	2020-03-28	2019-12-28	2019-09-28	2019-06-29	2019-03-30	2018-12-29	2018-09-29	2018-06-30	2018-03-31	2017-12-30	2017-09-30	2017-07-01	2017-04-01	2016-12-31	2016-10-01	2016-07-02	2016-04-02	2015-12-26	2015-09-26	2015-06-27	2015-03-28	2014-12-27	2014-09-27	2014-06-28	2014-03-29	2013-12-28	2013-09-28	2013-06-29	2013-03-30	2012-12-29	2012-09-29	2012-06-30	2012-03-31	2011-12-31	2011-10-01	2011-07-02	2011-04-02	2011-01-01	2010-10-02	2010-07-03	2010-04-03	2009-12-26	2009-09-26	2009-06-27	2009-03-28	2008-12-27	2008-09-27	2008-06-28	2008-03-29	2007-12-29	2007-09-29	2007-06-30	2007-03-31	2006-12-30	2006-09-30	2006-07-01	2006-04-01	2005-12-31	2005-10-01	2005-07-02

net revenues	346,351,000	338,967,000	327,315,000	321,394,000	330,599,000	348,542,000	345,511,000	336,172,000	343,290,000	336,250,000	318,183,000	311,332,000	304,416,000	305,301,000	297,485,000	261,458,000	265,002,000	259,769,000	239,897,000	228,528,000	225,029,000	240,371,000	209,486,000	195,577,000	238,492,000	258,970,000	252,566,000	238,451,000	249,295,000	247,356,000	241,581,000	229,347,000	233,552,000	234,043,000	225,377,000	210,951,000	228,066,000	227,841,000	220,253,000	209,956,000	242,342,000	233,384,000	219,693,000	213,413,000	226,478,000	231,827,000	227,580,000	224,488,000	241,091,000	242,120,000	235,755,000	219,543,000	249,942,000	247,395,000	218,178,000	176,475,000	186,670,000	191,160,000	179,445,000	170,569,000	170,033,000	176,789,000	166,833,000	163,039,000	169,104,000	165,169,000	157,070,000	154,087,000	152,397,000	155,447,000	145,919,000	144,116,000				121,936,000	116,919,000	113,527,000	108,487,000	110,674,000	110,395,000	105,677,000	100,488,000	103,173,000
cost of goods sold	148,139,000	136,581,000	132,571,000	129,150,000	137,549,000	154,995,000	158,074,000	161,248,000	167,384,000	158,383,000	147,673,000	144,067,000	148,167,000	146,594,000	139,607,000	119,195,000	128,691,000	121,204,000	117,356,000	120,443,000	143,222,000	120,114,000	103,742,000	105,547,000	124,935,000	130,920,000	125,566,000	122,545,000	138,085,000	136,181,000	129,674,000	146,103,000	129,166,000	122,748,000	120,815,000	119,286,000	145,955,000	126,762,000	116,005,000	118,900,000	153,119,000	124,529,000	114,396,000	110,874,000	118,113,000	120,166,000	119,466,000	118,210,000	125,650,000	120,491,000	115,871,000	108,131,000	126,801,000	134,280,000	116,416,000	86,362,000	92,059,000	95,229,000	89,496,000	81,821,000	82,532,000	83,299,000	79,078,000	76,576,000	80,980,000	79,722,000	76,103,000	71,144,000	70,249,000	77,151,000	71,230,000	71,079,000				60,442,000	58,572,000	57,108,000	53,326,000	53,301,000	51,818,000	50,008,000	48,723,000	48,649,000
gross profit	198,212,000	202,386,000	194,744,000	192,244,000	193,050,000	193,547,000	187,437,000	174,924,000	175,906,000	177,867,000	170,510,000	167,265,000	156,249,000	158,707,000	157,878,000	142,263,000	136,311,000	138,565,000	122,541,000	108,085,000	81,807,000	120,257,000	105,744,000	90,030,000	113,557,000	128,050,000	127,000,000	115,906,000	111,210,000	111,175,000	111,907,000	83,244,000	104,386,000	111,295,000	104,562,000	91,665,000	82,111,000	101,079,000	104,248,000	91,056,000	89,223,000	108,855,000	105,297,000	102,539,000	108,365,000	111,661,000	108,114,000	106,278,000	115,441,000	121,629,000	119,884,000	111,412,000	123,141,000	113,115,000	101,762,000	90,113,000	94,611,000	95,931,000	89,949,000	88,748,000	87,501,000	93,490,000	87,755,000	86,463,000	88,124,000	85,447,000	80,967,000	82,943,000	82,148,000	78,296,000	74,689,000	73,037,000				61,494,000	58,347,000	56,419,000	55,162,000	57,373,000	58,577,000	55,669,000	51,765,000	54,524,000
yoy	2.67%	4.57%	3.90%	9.90%	9.75%	8.82%	9.93%	4.58%	12.58%	12.07%	8.00%	17.57%	14.63%	14.54%	28.84%	31.62%	66.63%	15.22%	15.88%	20.05%	-27.96%	-6.09%	-16.74%	-22.32%	2.11%	15.18%	13.49%	39.24%	6.54%	-0.11%	7.02%	-9.19%	27.13%	10.11%	0.30%	0.67%	-7.97%	-7.14%	-1.00%	-11.20%	-17.66%	-2.51%	-2.61%	-3.52%	-6.13%	-8.20%	-9.82%	-4.61%	-6.25%	7.53%	17.81%	23.64%	30.16%	17.91%	13.13%	1.54%	8.13%	2.61%	2.50%	2.64%	-0.71%	9.41%	8.38%	4.24%	7.27%	9.13%	8.41%	13.56%				18.77%				7.18%	-0.39%	1.35%	6.56%	5.23%
qoq	-2.06%	3.92%	1.30%	-0.42%	-0.26%	3.26%	7.15%	-0.56%	-1.10%	4.31%	1.94%	7.05%	-1.55%	0.53%	10.98%	4.37%	-1.63%	13.08%	13.37%	32.12%	-31.97%	13.72%	17.45%	-20.72%	-11.32%	0.83%	9.57%	4.22%	0.03%	-0.65%	34.43%	-20.25%	-6.21%	6.44%	14.07%	11.64%	-18.77%	-3.04%	14.49%	2.05%	-18.04%	3.38%	2.69%	-5.38%	-2.95%	3.28%	1.73%	-7.94%	-5.09%	1.46%	7.60%	-9.52%	8.86%	11.16%	12.93%	-4.75%	-1.38%	6.65%	1.35%	1.43%	-6.41%	6.54%	1.49%	-1.88%	3.13%	5.53%	-2.38%	0.97%	4.92%	4.83%	2.26%					5.39%	3.42%	2.28%	-3.85%	-2.06%	5.22%	7.54%	-5.06%
operating expenses:
research and development	14,446,000	14,187,000	14,872,000	16,261,000	15,914,000	15,829,000	16,530,000	14,449,000	15,857,000	13,265,000	12,665,000	12,648,000	15,644,000	12,689,000	10,896,000	10,902,000	13,210,000	10,037,000	10,853,000	12,701,000	10,843,000	7,501,000	6,763,000	7,750,000	8,974,000	7,000,000	7,422,000	7,487,000	8,747,000	8,978,000	8,583,000	9,406,000	11,087,000	12,427,000	7,521,000	8,193,000	9,321,000	8,462,000	8,336,000	11,437,000	11,149,000	10,942,000	11,553,000	11,321,000	17,225,000	10,643,000	10,938,000	15,382,000	13,836,000	14,209,000	14,946,000	11,209,000	13,571,000	10,588,000	10,827,000	9,409,000	8,611,000	9,232,000	10,350,000										4,225,250	5,840,000	5,217,000					6,276,000	6,539,000	5,804,000	6,119,000	5,422,000	5,229,000	9,463,000	6,283,000	5,541,000
selling, general and administrative	120,933,000	109,154,000	101,615,000	110,719,000	115,136,000	106,459,000	106,946,000	108,248,000	121,681,000	111,713,000	104,901,000	93,485,000	97,376,000	94,661,000	92,411,000	92,227,000	91,841,000	80,726,000	75,778,000	91,218,000	59,508,000	73,446,000	71,697,000	69,537,000	78,574,000	78,267,000	69,839,000	73,000,000	78,607,000	73,877,000	77,248,000	68,545,000	79,024,000	97,855,000	72,783,000	66,861,000	73,087,000	70,956,000	71,118,000	87,500,000	76,277,000	78,940,000	74,565,000	87,612,000	74,161,000	82,758,000	84,769,000	92,562,000	87,248,000	89,560,000	81,508,000	106,811,000	87,615,000	86,780,000	81,034,000	67,625,000	65,040,000	61,376,000	62,613,000	56,231,000	49,820,000	56,935,000	52,790,000	54,354,000	37,614,750	53,151,000	47,469,000	49,839,000	35,421,750	47,965,000	45,863,000	47,859,000				39,439,000	31,815,000	33,610,000	34,741,000	36,908,000	29,510,000	31,250,000	30,103,000	30,488,000
amortization of acquired intangible assets	10,491,000	10,933,000	11,182,000	11,392,000	11,296,000	12,230,000	12,264,000	12,471,000	10,425,000	6,911,000	7,222,000	7,473,000
impairment of intangible assets	77,246,000	716,000	8,584,000								10,419,000
total operating expenses	221,237,000	134,990,000	136,253,000	138,372,000	121,715,000	134,518,000	135,740,000	135,168,000	145,963,000	131,889,000	135,207,000	113,606,000	120,994,000	115,428,000	111,146,000	111,496,000	117,112,000	102,914,000	98,031,000	106,695,000	102,982,000	79,832,000	46,962,000	78,315,000	87,550,000	87,143,000	77,261,000	129,208,000	87,354,000	82,855,000	85,831,000	77,951,000	90,111,000	110,282,000	80,304,000	75,054,000	139,617,000	79,867,000	79,454,000	98,937,000	94,773,000	170,032,000	86,118,000	98,933,000	96,827,000	93,401,000	95,707,000	107,944,000	102,795,000	103,769,000	96,454,000	118,020,000	105,433,000	97,368,000	91,861,000	77,034,000	73,651,000	70,608,000	71,383,000	64,840,000	58,606,000	64,931,000	58,850,000	62,274,000	84,027,000	59,612,000	53,944,000	56,616,000	64,015,000	53,805,000	51,080,000	53,703,000				45,715,000	32,654,000	39,414,000	50,006,000	42,330,000			36,386,000	36,029,000
operating income	-23,025,000	67,396,000	58,491,000	53,872,000	71,335,000	59,029,000	51,697,000	39,756,000	29,943,000	45,978,000	35,303,000	53,659,000	35,255,000	43,279,000	46,732,000	30,767,000	19,199,000	35,651,000	24,510,000	1,390,000	-21,175,000	40,425,000	58,782,000	11,715,000	26,007,000	40,907,000	49,739,000	-13,302,000	23,856,000	28,320,000	26,076,000	5,293,000	14,275,000	1,013,000	24,258,000	16,611,000	-57,506,000	21,212,000	24,794,000	-7,881,000	-5,550,000	-61,177,000	19,179,000	3,606,000	11,538,000	18,260,000	12,407,000	-1,666,000	12,646,000	17,860,000	23,430,000	-6,608,000	17,708,000	15,747,000	9,901,000	13,079,000	20,960,000	25,323,000	18,566,000	23,908,000	28,895,000	28,559,000	28,905,000	24,189,000	4,097,000	25,835,000	27,023,000	26,327,000	18,133,000	24,491,000	23,609,000	19,334,000				15,779,000	25,693,000	17,005,000	5,156,000	15,043,000	23,838,000	41,306,000	15,379,000	18,495,000
yoy	-132.28%	14.17%	13.14%	35.51%	138.24%	28.39%	46.44%	-25.91%	-15.07%	6.24%	-24.46%	74.40%	83.63%	21.40%	90.67%	2113.45%	-190.67%	-11.81%	-58.30%	-88.13%	-181.42%	-1.18%	18.18%	-188.07%	9.02%	44.45%	90.75%	-351.31%	67.12%	2695.66%	7.49%	-68.14%	-124.82%	-95.22%	-2.16%	-310.77%	936.14%	-134.67%	29.28%	-318.55%	-148.10%	-435.03%	54.58%	-316.45%	-8.76%	2.24%	-47.05%	-74.79%	-28.59%	13.42%	136.64%	-150.52%	-15.52%	-37.82%	-46.67%	-45.29%	-27.46%	-11.33%	-35.77%	-1.16%	605.27%	10.54%	6.96%	-8.12%	-77.41%	5.49%	14.46%	36.17%				22.53%				4.89%	7.78%	-58.83%	-66.47%	-18.66%
qoq	-134.16%	15.22%	8.57%	-24.48%	20.85%	14.18%	30.04%	32.77%	-34.88%	30.24%	-34.21%	52.20%	-18.54%	-7.39%	51.89%	60.25%	-46.15%	45.45%	1663.31%	-106.56%	-152.38%	-31.23%	401.77%	-54.95%	-36.42%	-17.76%	-473.92%	-155.76%	-15.76%	8.61%	392.65%	-62.92%	1309.18%	-95.82%	46.04%	-128.89%	-371.10%	-14.45%	-414.60%	42.00%	-90.93%	-418.98%	431.86%	-68.75%	-36.81%	47.17%	-844.72%	-113.17%	-29.19%	-23.77%	-454.57%	-137.32%	12.45%	59.04%	-24.30%	-37.60%	-17.23%	36.39%	-22.34%	-17.26%	1.18%	-1.20%	19.50%	490.41%	-84.14%	-4.40%	2.64%	45.19%	-25.96%	3.74%	22.11%					-38.59%	51.09%	229.81%	-65.72%	-36.89%	-42.29%	168.59%	-16.85%
interest and other expense	-5,374,000	-7,421,000	-7,206,000		-598,000	-9,112,000	-6,993,000		-6,529,000	-1,949,000	-2,471,000	-2,069,000	-2,629,000	-1,055,000	-5,673,000	-5,273,000	-3,872,000	-4,263,000	-4,588,000	-4,398,000	-6,222,000	-3,051,000	-3,826,000	-3,735,000	-4,047,000	-3,078,000	-4,651,000	-4,423,000	-2,037,000	-2,858,000	-3,039,000	-1,978,000	-963,000	-806,000	-1,397,000	-1,359,000	-1,603,500	-2,275,000	-1,962,000		-1,689,000	-2,141,000	-2,606,000		-1,874,000	-2,308,000	-2,645,000	-2,543,000	-2,008,750	-2,852,000	-2,542,000
income before provision for income taxes	-28,399,000	59,975,000	51,285,000	45,169,000	70,737,000	49,917,000	44,704,000	46,713,000	23,414,000	44,029,000	32,832,000	51,590,000	32,626,000	42,224,000	41,059,000	25,494,000	15,327,000	31,388,000	19,922,000	-3,008,000	-27,397,000	37,374,000	54,956,000	7,980,000	21,960,000	37,829,000	45,088,000	-17,725,000	21,819,000	25,462,000	23,037,000	3,315,000	13,312,000	207,000	22,861,000	23,252,000	-59,187,000	18,937,000	22,832,000		-8,268,000	-63,318,000	16,573,000		9,659,000	15,952,000	9,762,000		9,755,000	15,008,000	20,888,000	-9,249,000	14,686,000	13,205,000	8,590,000	13,415,000	21,330,000	25,463,000	19,011,000	23,693,000	28,572,000	27,974,000	29,159,000	24,375,000	3,888,000	25,377,000	26,070,000	25,935,000	18,365,000	23,489,000	22,809,000	20,339,000				18,432,000	28,416,000	19,404,000	7,111,000	17,556,000	25,842,000	44,488,000	16,421,000	20,131,000
provision for income taxes	-8,252,000	15,235,000	12,601,000	11,138,000	12,756,000	12,423,000	10,873,000	8,340,000	3,047,000	12,788,000	7,924,000	10,548,000	3,243,000	9,280,000	7,862,000	5,617,000	5,586,000	8,156,000	5,066,000	1,446,000	-16,356,000	5,492,000	6,855,000		4,336,000	7,934,000	7,602,000	-9,246,000	984,000	7,185,000	4,311,000	6,134,000	1,432,000	6,754,000	2,759,000	3,115,000	-8,047,000	3,544,000	3,007,000		467,000	-3,878,000	3,710,000		12,589,000	-36,000	2,275,000						2,125,000	3,301,000	2,043,000	3,628,000	3,524,000	7,211,000	5,131,000	6,746,000	7,584,000	8,240,000	7,821,000	6,457,000	-73,000	7,091,000	8,020,000	7,862,000	4,426,000	7,273,000	8,002,000	5,998,000				5,755,000	8,632,000	2,503,000	5,845,000	6,248,000	8,684,000	16,399,000	5,476,000	7,247,000
net income	-20,147,000	44,740,000	38,684,000	34,031,000	57,981,000	37,494,000	33,831,000	38,373,000	20,367,000	31,241,000	24,908,000	41,042,000	29,383,000	32,944,000	33,197,000	19,877,000	9,741,000	23,232,000	14,856,000	-4,454,000	-11,041,000	31,882,000	48,101,000	10,527,000	17,624,000	29,895,000	37,486,000	-8,479,000	20,835,000	18,277,000	18,726,000	-2,819,000	11,880,000	-6,547,000	20,102,000	20,137,000	-51,140,000	15,393,000	19,825,000	-10,346,000	-8,735,000	-59,440,000	12,863,000	-267,000	-2,930,000	15,988,000	7,487,000	-3,649,000	10,184,000	16,290,000	16,548,000	-7,874,000	12,561,000	9,904,000	6,547,000	9,787,000	17,806,000	18,252,000	13,880,000	16,947,000	20,988,000	19,734,000	21,338,000	17,918,000	3,961,000	18,286,000	18,050,000	18,073,000	13,939,000	16,216,000	14,807,000	14,341,000				12,677,000	19,785,000	16,902,000	1,266,000	11,308,000	17,158,000	28,089,000	10,945,000	12,884,000
yoy	-134.75%	19.33%	14.34%	-11.32%	184.68%	20.02%	35.82%	-6.50%	-30.68%	-5.17%	-24.97%	106.48%	201.64%	41.80%	123.46%	-546.27%	-188.23%	-27.13%	-69.11%	-142.31%	-162.65%	6.65%	28.32%	-224.15%	-15.41%	63.57%	100.18%	200.78%	75.38%	-379.17%	-6.85%	-114.00%	-123.23%	-142.53%	1.40%	-294.64%	485.46%	-125.90%	54.12%	3774.91%	198.12%	-471.78%	71.80%	-92.68%	-128.77%	-1.85%	-54.76%	-53.66%	-18.92%	64.48%	152.76%	-180.45%	-29.46%	-45.74%	-52.83%	-42.25%	-15.16%	-7.51%	-34.95%	-5.42%	429.87%	7.92%	18.22%	-0.86%	-71.58%	12.77%	21.90%	26.02%				13.13%				12.11%	15.31%	-39.83%	-88.43%	-12.23%
qoq	-145.03%	15.66%	13.67%	-41.31%	54.64%	10.83%	-11.84%	88.41%	-34.81%	25.43%	-39.31%	39.68%	-10.81%	-0.76%	67.01%	104.06%	-58.07%	56.38%	-433.54%	-59.66%	-134.63%	-33.72%	356.93%	-40.27%	-41.05%	-20.25%	-542.10%	-140.70%	14.00%	-2.40%	-764.28%	-123.73%	-281.46%	-132.57%	-0.17%	-139.38%	-432.23%	-22.36%	-291.62%	18.44%	-85.30%	-562.10%	-4917.60%	-90.89%	-118.33%	113.54%	-305.18%	-135.83%	-37.48%	-1.56%	-310.16%	-162.69%	26.83%	51.28%	-33.11%	-45.04%	-2.44%	31.50%	-18.10%	-19.25%	6.35%	-7.52%	19.09%	352.36%	-78.34%	1.31%	-0.13%	29.66%	-14.04%	9.52%	3.25%					-35.93%	17.06%	1235.07%	-88.80%	-34.09%	-38.92%	156.64%	-15.05%
net income per common share:
basic	-2,467.94	960	810	710
diluted	-2,457.95	950	810	700
weighted-average shares outstanding
basic	47,179	46,792,000	47,590,000	48,111,000	50,330	50,286	50,898	50,943	50,706	50,768	50,727	50,542	50,783	50,509	50,953	51,224	51,047	51,094	51,039	50,939	50,688	50,789	50,696	50,418	50,692	50,630	50,791		51,533	51,401	51,605	52,119	52,755	53,090	52,619	52,443	51,524	51,708	51,378	51,021	50,910	50,741	50,680	51,360	51,533	51,432	51,391	51,741	51,611	51,730	51,492	51,231	51,349	51,707	25,710	25,483	25,364,000	25,077	25,418,000	25,731,000	25,077,000	24,973,000	24,686,000	25,140,000	25,451,000	25,289,000	25,685,000	25,658,000	25,389,000			25,607,000					26,746,000	26,527,000	27,087,000		26,478,000		26,395,000
diluted	47,354	46,987,000	47,664,000	48,353,000	50,730	50,639	51,240	51,564	51,397	51,445	51,396	51,340	51,420	51,219	51,558	51,683	51,353	51,344	51,458	50,939	51,292	51,363	51,093	51,247	51,815	51,638	52,046		52,942	52,822	53,138	52,119	53,501	53,090	52,981	52,811	51,524	52,103	51,701	51,021	50,910	50,741	51,187	51,360	52,089	51,962	51,925	51,741	52,377	52,511	52,361	51,231	52,259	52,606	26,157	25,932	25,795,000	25,438	25,843,000	26,216,000	25,596,000	25,517,000	25,228,000	25,703,000	26,063,000	25,907,000	26,321,000	26,201,000	26,173,000			26,517,000					27,649,000	27,367,000	27,969,000		27,474,000		27,354,000
interest and other income				-8,703,000				6,957,000																																-2,177,000				-2,009,000
net income per share					1.17	0.75	0.66	0.75	0.4	0.62	0.49	0.81	0.58	0.65	0.65	0.39	0.19	0.45	0.29	-0.09	-0.22	0.63	0.95	0.21	0.35	0.59	0.74	-0.17	0.41	0.36	0.36	-0.05	0.22	-0.12	0.38	0.38	-0.99	0.3		-0.2	-0.17	-1.17	0.25	-0.01	-0.05	0.31	0.15	-0.07	0.2	0.31	0.32	-0.15	0.25	0.19	0.25	0.38	0.483	0.73
comprehensive income					22,457.25	16,557	41,934	31,338	25,797.5	39,564	21,721	41,905	19,043.25	37,400	25,659	13,114	8,458	23,419	14,420	-4,007	26,446.75	40,496	53,335	11,956	13,894.25	32,296	35,378		6,019.75	13,214	18,403	-7,538	9,838.25	-6,350	21,937	23,766	5,222	13,084	19,037		-16,617.25	-62,316	-1,526		2,710.25	8,346	6,990		6,115.5	17,289	15,308	-8,134	6,005	12,239	5,863	5,918
amortization of intangible assets													6,166,500	8,078,000	8,221,000	8,367,000	11,484,000	12,151,000	11,400,000	12,379,000
gains on divestiture													-95,500		-382,000
gains on divestitures and sale of assets																				-9,603,000	-199,000	-1,115,000	-31,498,000
impairment of assets																								1,028,000	2,000	1,876,000		48,721,000									57,209,000	449,000
benefit for income taxes																								-2,547,000
weighted-average shares outstanding
basic and diluted																												51,010
comprehensive loss																												-12,097												-11,233				-2,627				-4,495
gain on divestiture																																				8,000,000
contingent consideration income																																																											-1,580,000				-1,894,000
earnings per share - basic																																							0.39
earnings per share - diluted																																							0.38
income before benefit from income taxes																																								-10,058,000				1,597,000
benefit from income taxes																																								288,000				1,864,000
impairment of goodwill and intangible assets																																									21,262,000	85,048,000
contingent consideration expense																																										-4,898,000
loss before benefit from income taxes																																																-4,209,000
income tax benefit																																																-560,000
income tax expense																																																	420,500	-1,282,000	4,340,000	-1,375,000
other income																																																				-2,641,000	-3,022,000	-2,542,000	-1,311,000	336,000	370,000	140,000	445,000	-215,000			-216,000	237,000				-335,000				375,000				957,000	830,000	816,000	425,000				481,000	864,000
basic income per common share																																																																																420	492.5	1,060	420	490
income per common share assuming dilution																																																																																400	472.5	1,020	400	470
research, development and engineering																																																												8,609,000	8,786,000	7,996,000	7,954,000	7,920,000	4,928,500	6,461,000	6,475,000	6,777,000				5,844,000
interest expense																																																												-106,000	-105,000	-111,000	-23,000	-153,000	-20,000	-248,000	-255,000	-214,000																-541,000
interest income																																																												106,000	83,000	91,000	493,000	102,000	90,000	56,000	103,000	157,000	399,000	449,000	506,000	630,000				1,903,000	1,962,000	1,925,000	1,951,000	2,026,000	1,692,000	2,875,000	1,083,000	1,313,000
other expense																																																													-301,000	-565,000			-347,250	-266,000	-801,000
weighted average shares outstanding
basic																																																																						25,375,000	25,038,000					26,534,000				26,900,000		26,542,000		26,280,000
diluted																																																																						26,056,000	25,917,000					27,403,000				27,929,000		27,646,000		27,209,000
cost to equity
other unusual charges relating to acquisition																																																																													56,250		73,000
in process research and development																																																																													2,268,250		9,073,000
arbitration award income
operating expenses and income:
other income net																																																																																912,000
total operating expenses and income																																																																																	21,694,500	14,363,000
other income (expense)																																																																																	731,000	742,000

Balance Sheets:

Quarterly

Annual

Unit: USD	2026-03-28	2025-12-27	2025-09-27	2025-06-28	2025-03-29	2024-12-28	2024-09-28	2024-06-29	2024-03-30	2023-12-30	2023-09-30	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2022-01-01	2021-10-02	2021-07-03	2021-04-03	2020-12-26	2020-09-26	2020-06-27	2020-03-28	2019-12-28	2019-09-28	2019-06-29	2019-03-30	2018-12-29	2018-09-29	2018-06-30	2018-03-31	2017-12-30	2017-09-30	2017-07-01	2017-04-01	2016-12-31	2016-10-01	2016-07-02	2016-04-02	2015-12-26	2015-09-26	2015-06-27	2015-03-28	2014-12-27	2014-09-27	2014-06-28	2014-03-29	2013-12-28	2013-09-28	2013-06-29	2013-03-30	2012-12-29	2012-09-29	2012-06-30	2012-03-31	2011-12-31	2011-10-01	2011-07-02	2011-04-02	2011-01-01	2010-10-02	2010-07-03	2010-04-03	2009-12-26	2009-09-26	2009-06-27	2009-03-28	2008-12-27	2008-09-27	2008-06-28	2008-03-29	2007-12-29	2007-09-29	2007-06-30	2007-03-31	2006-12-30	2006-09-30	2006-07-01	2006-04-01	2005-12-31	2005-10-01	2005-07-02

assets
current assets:
cash and cash equivalents	245,440,000	363,367,000	296,426,000	292,898,000	306,763,000	320,846,000	299,283,000	344,429,000	178,800,000	193,978,000	351,005,000	285,719,000	284,466,000	224,002,000	241,200,000	214,948,000	259,496,000	236,877,000	192,420,000	173,462,000	192,305,000	189,002,000	279,169,000	275,725,000	137,311,000	126,417,000	112,030,000	190,234,000	169,351,000	154,871,000	199,763,000	192,106,000	180,169,000	251,591,000	203,622,000	171,739,000	139,564,000	129,639,000	138,870,000	118,248,000	115,123,000	105,167,000	100,247,000	112,204,000	160,662,000	125,200,000	129,971,000	139,943,000	192,469,000	177,846,000	159,148,000	166,328,000	179,120,000	193,181,000	187,051,000	236,047,000	228,861,000	205,372,000	183,421,000	216,891,000	196,707,000	169,538,000	115,049,000	83,467,000	141,562,000	168,993,000	178,322,000	173,822,000	156,721,000	125,325,000	111,331,000	120,287,000				216,056,000	229,227,000	227,707,000	242,200,000	260,031,000	250,667,000	229,351,000	209,981,000	198,067,000
accounts receivables	216,855,000	195,707,000	207,066,000	200,752,000	202,657,000	211,949,000	213,534,000	201,485,000	206,562,000	211,611,000	174,249,000	177,117,000	179,142,000	181,100,000	171,532,000	146,463,000	159,376,000	154,980,000	141,305,000	132,908,000	127,555,000	146,939,000	141,533,000	141,094,000	165,207,000	170,753,000	176,535,000	163,339,000	185,027,000	167,641,000	161,590,000	151,336,000	151,226,000	146,718,000	143,693,000	151,507,000	152,683,000	150,557,000	151,600,000	149,668,000	157,093,000	148,774,000	145,411,000	139,103,000	145,827,000	143,635,000	151,055,000	156,733,000	164,603,000	149,585,000	162,084,000	155,958,000	170,111,000	167,347,000	158,175,000	126,130,000	135,464,000	127,443,000	129,242,000	120,759,000	127,166,000	120,373,000	121,767,000	114,834,000	118,684,000	114,732,000	118,668,000	114,161,000	113,598,000	124,575,000	122,500,000	127,931,000				91,917,000	91,832,000	85,988,000	84,001,000	89,281,000	86,901,000	86,262,000	83,409,000	83,625,000
inventories	306,370,000	321,185,000	336,206,000	360,527,000	365,141,000	359,614,000	382,105,000	373,787,000	317,202,000	304,024,000	285,830,000	289,207,000	259,379,000	255,756,000	254,680,000	277,887,000	293,027,000	305,741,000	322,661,000	326,500,000	322,614,000	299,710,000	305,224,000	294,510,000	270,276,000	254,167,000	244,504,000	221,953,000	194,337,000	168,936,000	163,584,000	175,329,000	160,799,000	158,840,000	168,592,000	173,894,000	176,929,000	188,489,000	194,511,000	189,431,000	187,028,000	203,863,000	207,645,000	211,131,000	211,077,000	212,493,000	209,418,000	207,487,000	197,661,000	209,331,000	205,251,000	196,673,000	183,784,000	180,037,000	173,506,000	126,843,000	117,163,000	107,913,000	101,444,000	94,960,000	84,387,000	81,915,000	86,009,000	84,571,000	79,953,000	78,806,000	77,136,000	76,097,000	76,522,000	73,557,000	73,181,000	71,196,000				68,209,000	61,797,000	59,680,000	58,925,000	55,561,000	54,571,000	56,313,000	57,581,000	55,998,000
prepaid expenses and other current assets	66,214,000	63,415,000	59,984,000	58,983,000	60,414,000	113,459,000	60,980,000	58,877,000	66,339,000	55,369,000	54,660,000	49,564,000	46,735,000	45,451,000	48,377,000	48,485,000	44,132,000	31,857,000	42,860,000	51,498,000	51,072,000	32,697,000	34,353,000	48,081,000	30,845,000	31,238,000	34,720,000	39,752,000	27,406,000	24,449,000	27,868,000	32,246,000	28,983,000	32,564,000	37,482,000	30,949,000	40,853,000	27,877,000	27,406,000	32,248,000	28,842,000	31,564,000	35,444,000	33,243,000	40,103,000	52,331,000	52,366,000	50,969,000	54,099,000	52,392,000	51,144,000	58,072,000	50,213,000	47,510,000	47,425,000	40,588,000	35,976,000	16,958,000	17,203,000	25,729,000	30,897,000	20,794,000	25,517,000	29,924,000	34,959,000	22,799,000	21,514,000	23,601,000	28,362,000	21,944,000	23,482,000	21,878,000				15,820,000	9,067,000	12,151,000	15,815,000	15,760,000	15,109,000	19,296,000	17,005,000	15,517,000
total current assets	834,879,000	943,674,000	899,682,000	913,160,000	934,975,000	1,005,868,000	955,902,000	978,578,000	768,903,000	764,982,000	865,744,000	801,607,000	769,722,000	706,309,000	715,789,000	687,783,000	756,031,000	729,455,000	699,246,000	684,368,000	693,546,000	668,348,000	760,279,000	759,410,000	603,639,000	582,575,000	567,789,000	615,278,000	576,121,000	515,897,000	552,805,000	551,017,000	521,177,000	589,713,000	553,389,000	528,089,000	510,029,000	496,562,000	512,387,000	489,595,000	488,086,000	501,363,000	500,724,000	508,361,000	570,277,000	549,831,000	556,959,000	569,305,000	622,976,000	603,332,000	592,081,000	591,372,000	597,010,000	598,882,000	576,800,000	540,187,000	527,129,000	467,173,000	441,100,000	468,269,000	448,831,000	406,017,000	362,222,000	323,516,000	386,143,000	394,107,000	406,125,000	396,154,000	382,393,000	353,892,000	341,468,000	353,810,000				403,066,000	403,671,000	398,513,000	413,805,000	433,277,000	418,404,000	402,098,000	379,060,000	364,865,000
property, plant and equipment	305,761,000	297,234,000	292,476,000	286,865,000	284,052,000	286,107,000	300,478,000	302,480,000	311,362,000	318,665,000	307,766,000	304,467,000	310,885,000	313,138,000	307,844,000	288,321,000	258,482,000	238,841,000	223,747,000	214,782,000	217,559,000	240,009,000	240,405,000	242,969,000	253,399,000	268,104,000	264,238,000	276,748,000	343,979,000	351,108,000	344,560,000	315,873,000	332,156,000	330,026,000	320,221,000	321,953,000	323,862,000	335,957,000	339,843,000	339,666,000	337,634,000	332,772,000	328,233,000		321,948,000
intangible assets, less accumulated amortization of 363,763 as of march 28, 2026 and 316,313 as of march 29, 2025	447,655,000
goodwill	656,368,000	606,825,000	606,101,000	607,299,000	604,269,000	605,266,000	616,162,000	613,347,000	565,082,000	554,999,000	465,405,000	465,910,000	466,231,000	466,112,000	464,987,000	466,115,000	467,287,000	468,199,000	468,590,000	466,314,000	466,444,000	215,508,000	214,594,000	217,298,000	210,652,000	211,062,000	211,041,000	211,140,000	210,819,000	210,723,000	210,844,000	210,903,000	211,395,000	211,086,000	211,125,000	210,930,000	210,841,000	267,314,000	268,546,000	268,589,000	267,840,000	266,945,000	333,575,000	334,187,000	334,310,000	334,990,000	336,301,000	337,237,000	336,768,000	337,029,000	341,673,000	341,509,000	330,474,000	321,284,000	322,114,000	115,048,000	115,058,000	115,320,000	115,582,000	115,707,000	115,367,000	111,268,000	112,383,000	117,739,000	120,543,000	71,255,000	72,157,000	64,730,000	56,426,000	55,434,000	54,556,000	54,786,000				34,703,000	34,958,000	33,548,000	33,494,000	18,625,000	18,483,000	18,437,000	18,730,000	17,936,000
deferred tax asset	9,521,000	7,329,000	7,571,000	7,843,000	7,803,000	8,000,000	9,083,000	9,369,000	7,739,000	5,070,000	4,745,000	4,875,000	5,241,000	4,842,000	4,282,000	4,552,000	4,468,000	6,050,000	6,064,000	6,197,000	6,009,000	4,558,000	4,306,000	4,088,000	3,930,000	4,428,000	4,328,000	4,622,000	4,359,000	3,702,000	3,765,000	3,774,000	3,961,000	4,510,000	4,478,000							11,995,000	11,977,000	12,680,000	12,608,000	16,172,000	14,149,000	14,173,000	14,144,000	14,178,000	14,454,000	14,341,000	13,782,000	10,807,000	10,643,000	10,579,000	9,665,000	9,487,000	9,790,000	9,930,000	9,674,000	13,397,000	13,880,000	10,720,000		8,777,000	10,485,000	8,473,000	7,190,000	8,491,000	10,974,000	12,518,000				11,064,000	11,748,000	12,987,000	12,864,000	12,644,000	11,156,000	10,876,000	11,084,000	11,658,000
other long-term assets	141,741,000	216,094,000	207,969,000	196,293,000	164,106,000	160,414,000	155,762,000	142,268,000	136,388,000	127,442,000	117,111,000	117,253,000	106,975,000	103,282,000	79,615,000	71,045,000	63,205,000	64,880,000	66,601,000	68,838,000	70,882,000	69,929,000	71,380,000	71,888,000	62,384,000	64,273,000	29,605,000	31,482,000	11,796,000	11,483,000	12,254,000	10,871,000	12,061,000	12,433,000	12,571,000	12,591,000	12,449,000	13,586,000	13,657,000	13,848,000	14,055,000	15,243,000	15,674,000	11,028,000	11,271,000	13,581,000	10,671,000	10,410,000	10,654,000	10,389,000	13,409,000	10,924,000	11,341,000	16,651,000	16,535,000	11,079,000	10,719,000	9,760,000	9,974,000	10,203,000	10,458,000	9,401,000	9,919,000	9,328,000	9,664,000	5,534,000	5,635,000	4,898,000	4,799,000	4,832,000	4,792,000	5,081,000				4,746,000	4,961,000	4,071,000	4,280,000	10,938,000	10,208,000	9,451,000	9,287,000	9,641,000
total assets	2,395,925,000	2,490,890,000	2,442,156,000	2,462,094,000	2,450,948,000	2,531,270,000	2,525,224,000	2,540,977,000	2,195,591,000	2,200,428,000	2,011,275,000	1,962,258,000	1,934,825,000	1,878,066,000	1,865,112,000	1,820,526,000	1,859,734,000	1,831,376,000	1,801,497,000	1,794,187,000	1,819,923,000	1,318,068,000	1,418,174,000	1,433,173,000	1,267,110,000	1,237,749,000	1,190,541,000	1,259,610,000	1,274,767,000	1,227,637,000	1,265,711,000	1,241,168,000	1,237,339,000	1,311,714,000	1,271,163,000	1,251,382,000	1,238,709,000	1,306,421,000	1,334,826,000	1,317,391,000	1,319,128,000	1,336,422,000	1,418,944,000	1,427,411,000	1,485,417,000	1,474,145,000	1,474,545,000	1,476,731,000	1,514,178,000	1,487,893,000	1,484,246,000	1,479,630,000	1,461,917,000	1,474,373,000	1,454,555,000	928,123,000	911,135,000	847,773,000	823,722,000	853,406,000	833,264,000	783,388,000	737,737,000	697,595,000	760,660,000	702,212,000	714,294,000	691,943,000	649,693,000	622,348,000	600,710,000	608,229,000				578,104,000	572,735,000	549,868,000	561,432,000	568,234,000	546,543,000	523,136,000	499,223,000	485,862,000
liabilities and stockholders’ equity
current liabilities:
notes payable and current maturities of long-term debt	5,015,000	304,746,000	304,335,000	303,949,000	303,558,000	5,075,000	5,434,000	5,109,000	10,229,000	13,736,000	13,566,000	13,572,000	11,784,000	9,949,000	58,194,000	6,853,000	214,148,000	144,064,000	82,733,000	17,025,000	17,016,000	17,055,000	167,001,000	231,364,000	76,980,000	61,966,000	56,934,000	117,548,000	27,666,000	17,199,000	12,664,000	17,043,000	194,259,000	151,465,000	108,589,000	65,876,000	61,022,000	66,271,000	51,549,000	46,804,000	43,471,000	46,293,000	46,593,000	32,396,000	21,522,000	7,748,000	1,655,000	1,931,000	45,630,000	40,810,000	43,687,000	32,434,000	23,150,000	14,197,000	4,249,000	2,417,000	894,000	2,545,000	3,080,000	906,000	913,000	8,244,000	11,702,000	6,418,000	16,062,000	15,132,000	15,181,000	17,200,000	695,000	4,434,000	8,055,000	9,028,000				18,601,000	22,201,000	23,248,000	21,922,000	22,226,000	26,176,000	25,796,000	27,643,000	26,258,000
accounts payable	51,056,000	48,694,000	61,691,000	46,010,000	66,999,000	62,990,000	69,242,000	76,929,000	73,358,000	56,845,000	80,160,000	78,134,000	63,929,000	63,769,000	61,484,000	57,907,000	58,371,000	51,175,000	44,969,000	49,131,000	50,293,000	42,979,000	49,071,000	48,459,000	50,730,000	52,298,000	57,449,000	60,792,000	63,361,000	62,579,000	57,857,000	65,393,000	55,265,000	41,496,000	41,764,000	39,389,000	42,973,000	48,848,000	42,013,000	36,799,000	39,674,000	39,636,000	42,088,000	42,155,000	48,425,000	46,830,000	44,173,000	55,213,000	53,562,000	43,106,000	45,380,000	47,915,000	49,893,000	53,077,000	42,987,000	33,978,000	35,425,000	28,891,000	29,759,000	28,155,000	28,323,000	19,608,000	21,628,000	23,418,000	25,590,000	23,740,000	24,804,000	23,448,000	20,652,000	17,201,000	20,292,000	21,300,000				17,740,000	17,187,000	16,514,000	17,293,000	15,477,000	14,217,000	14,734,000	13,252,000	15,123,000
accrued payroll and related costs	68,191,000	52,099,000	48,269,000	35,805,000	59,423,000	45,933,000	49,300,000	40,768,000	80,708,000	58,762,000	45,638,000	32,970,000	64,475,000	52,182,000	44,596,000	30,422,000	48,540,000	39,046,000	41,067,000	34,372,000	47,600,000	35,127,000	29,226,000	36,409,000	49,471,000	44,425,000	38,848,000	31,352,000	53,200,000	51,811,000	49,132,000	45,828,000	69,519,000	63,066,000	37,364,000	31,934,000	43,534,000	41,556,000	40,808,000	44,330,000	35,798,000	38,204,000	42,852,000	40,092,000	51,115,000	48,028,000	55,840,000	49,495,000	54,913,000	44,581,000	44,101,000	41,523,000	45,697,000	40,897,000	40,376,000	25,162,000	29,451,000	24,970,000	26,780,000	23,001,000	27,039,000	26,138,000	30,330,000	25,240,000	39,046,000	28,036,000	24,197,000	21,369,000	30,771,000	24,967,000	21,705,000	20,774,000				14,903,000	14,522,000	16,263,000	16,000,000	15,992,000	18,318,000	16,849,000	14,417,000	12,712,000
other current liabilities	158,337,000	134,329,000	134,023,000	145,643,000	148,133,000	139,235,000	149,970,000	137,270,000	136,088,000	132,412,000	124,851,000	112,263,000	111,628,000	100,989,000	97,901,000	85,305,000	121,207,000				138,586,000				97,641,000				91,532,000				65,660,000				63,650,000				66,608,000	49,410,000	54,363,000		64,211,000
total current liabilities	282,599,000	539,868,000	548,318,000	531,407,000	578,113,000	253,233,000	273,946,000	260,076,000	300,383,000	261,755,000	264,215,000	236,939,000	251,816,000	226,889,000	262,175,000	180,487,000	442,266,000	355,411,000	288,470,000	228,339,000	253,495,000	194,384,000	338,568,000	407,827,000	274,822,000	256,692,000	240,066,000	293,665,000	235,759,000	211,282,000	189,167,000	193,995,000	384,703,000	324,178,000	254,999,000	205,523,000	211,179,000	216,221,000	198,664,000	198,973,000	185,551,000	175,334,000	188,105,000	169,765,000	189,092,000	164,340,000	165,056,000	165,868,000	216,928,000	189,008,000	198,188,000	187,795,000	180,144,000	177,610,000	156,194,000	121,906,000	130,744,000	109,368,000	110,806,000	103,019,000	108,671,000	105,530,000	113,751,000	102,013,000	136,497,000	107,145,000	112,823,000	104,052,000	92,863,000	85,534,000	87,186,000	97,280,000				86,115,000	82,017,000	85,949,000	88,115,000	89,582,000	88,116,000	86,070,000	87,899,000	89,143,000
long-term debt	1,219,565,000	919,987,000	920,393,000	920,833,000	921,230,000	1,219,762,000	1,219,523,000	1,218,477,000	797,564,000	856,849,000	748,662,000	751,381,000	754,102,000	756,826,000	759,552,000	763,141,000	559,441,000	633,118,000	698,043,000	767,345,000	690,592,000	292,721,000	297,016,000	296,893,000	305,513,000	309,738,000	313,984,000	318,144,000	322,454,000	326,618,000	330,988,000	330,838,000	59,423,000	118,702,000	178,015,000	237,167,000	253,625,000	269,997,000	336,505,000	352,908,000	364,529,000	380,814,000	387,715,000	399,453,000	406,369,000	421,006,000	428,253,000	429,010,000	392,057,000	406,418,000	420,711,000	448,119,000	456,944,000	468,250,000	477,402,000	2,642,000	2,877,000	3,107,000	3,332,000	3,606,000	3,966,000	4,194,000	4,423,000	4,384,000	4,589,000	4,778,000	4,974,000	5,160,000	5,343,000	5,522,000	5,697,000	5,882,000				6,522,000	6,675,000	6,828,000	12,690,000	12,835,000	12,977,000	13,117,000	18,967,000	19,101,000
deferred tax liability	38,048,000	55,979,000	58,201,000	59,488,000	62,575,000	61,451,000	62,893,000	64,793,000	62,644,000	62,246,000	34,807,000	37,342,000	36,195,000	40,152,000	35,974,000	32,622,000	28,727,000	26,132,000	24,574,000	24,278,000	43,825,000	9,803,000	10,480,000	13,116,000	10,562,000	14,576,000	11,687,000	14,006,000	19,906,000	18,441,000	13,235,000	10,606,000	6,526,000	6,428,000	13,380,000																			250,000	225,000	297,000	64,000	75,000	123,000	554,000	107,000	1,177,000	1,131,000	173,000	68,000	120,000	111,000		17,000
other long-term liabilities	59,393,000	63,605,000	66,071,000	68,066,000	68,194,000	89,964,000	90,011,000	92,263,000	75,041,000	76,259,000	69,931,000	71,980,000	74,715,000	78,220,000	78,402,000	73,853,000	79,876,000	85,940,000	91,861,000	97,145,000	100,341,000	102,008,000	104,187,000	106,768,000	89,104,000	82,163,000	41,050,000	42,829,000	28,780,000	28,167,000	30,983,000	31,670,000	34,258,000	39,599,000	23,516,000	23,104,000	22,181,000	24,843,000	28,355,000	28,534,000	26,106,000	27,212,000	31,463,000	32,192,000	31,737,000	29,020,000	33,607,000	38,415,000	37,641,000	37,583,000	39,609,000	39,377,000	26,095,000	23,858,000	22,480,000	21,752,000	21,551,000	13,290,000	13,302,000	15,939,000	15,822,000	13,268,000	12,490,000	12,730,000	12,915,000	13,551,000	13,363,000	13,007,000	8,474,000	7,849,000	7,759,000	7,884,000				8,912,000	4,395,000	3,747,000	3,637,000	3,982,000	3,800,000	4,976,000	5,107,000	5,049,000
stockholders’ equity:
common stock, 0.01 par value...	453,000	468,000	467,000	482,000	482,000	502,000	504,000	512,000	508,000	508,000	507,000	507,000	504,000	504,000	506,000	513,000	511,000	511,000	511,000	510,000	509,000	508,000	507,000	507,000	503,000	504,000	506,000	508,000	510,000	510,000	516,000	516,000	523,000	534,000	527,000	525,000	523,000	518,000	515,000	511,000	509,000	508,000	506,000	509,000	517,000	515,000	513,000	514,000	520,000	519,000	515,000	514,000	510,000	516,000			253,000			257,000	256,000	255,000	248,000	247,000		252,000	256,000	257,000		254,000	252,000	254,000								270,000		266,000	265,000	263,000
additional paid-in capital	554,137,000	564,502,000	552,914,000	562,014,000	523,264,000	569,629,000	544,375,000	560,881,000	634,627,000	627,094,000	616,960,000	609,610,000	594,706,000	587,489,000	564,394,000	580,359,000	572,476,000	566,963,000	558,156,000	551,108,000	602,727,000	579,480,000	568,748,000	562,729,000	553,229,000	537,913,000	533,720,000	525,038,000	536,320,000	531,131,000	530,480,000	507,394,000	503,955,000	525,877,000	497,980,000	491,436,000	482,044,000	468,348,000	459,651,000	445,138,000	439,912,000	435,477,000	430,488,000	427,878,000	426,964,000	417,405,000	408,940,000	404,686,000	402,611,000	396,607,000	385,153,000	378,366,000	365,040,000	362,199,000	354,389,000	341,401,000	322,485,000	312,887,000	304,517,000	310,083,000	302,709,000	289,906,000	256,071,000	251,113,000	252,323,000	236,553,000	235,792,000	232,221,000	226,829,000	217,036,000	209,427,000	193,413,000				172,763,000	163,815,000	157,700,000	157,175,000	149,945,000	141,371,000	134,781,000	130,723,000	126,804,000
retained earnings	279,344,000	381,091,000	336,323,000	356,046,000	352,174,000	392,230,000	368,536,000	386,642,000	360,456,000	340,099,000	308,898,000	284,017,000	253,168,000	223,785,000	204,364,000	222,268,000	202,391,000	192,650,000	169,418,000	154,562,000	157,981,000	169,022,000	137,140,000	89,039,000	78,512,000	69,868,000	85,634,000	99,418,000	161,418,000	140,584,000	194,375,000	189,859,000	266,942,000	323,608,000	330,155,000	310,053,000	289,916,000	341,056,000	325,663,000	305,838,000	316,184,000	324,916,000	384,359,000	387,344,000	420,365,000	423,563,000	411,199,000	409,307,000	433,347,000	423,163,000	406,873,000	390,324,000	398,199,000	409,553,000	412,764,000	410,569,000	400,783,000	382,977,000	364,726,000	390,577,000	373,630,000	352,642,000	332,907,000	311,568,000	334,641,000	330,680,000	339,323,000	327,589,000	309,516,000	295,576,000	279,360,000	291,462,000				302,515,000	315,767,000	295,982,000	301,622,000	314,153,000	302,845,000	285,687,000	257,598,000	246,653,000
accumulated other comprehensive loss	-37,614,000	-34,610,000	-40,531,000	-36,242,000	-55,084,000	-55,501,000	-34,564,000	-42,667,000	-35,632,000	-24,382,000	-32,705,000	-29,518,000	-30,381,000	-35,799,000	-40,255,000	-32,717,000	-25,954,000	-29,349,000	-29,536,000	-29,100,000	-29,547,000	-29,858,000	-38,472,000	-43,706,000	-45,135,000	-33,705,000	-36,106,000	-33,998,000	-30,380,000	-29,096,000	-24,033,000	-23,710,000	-18,991,000	-27,212,000	-27,409,000	-29,244,000	-32,873,000	-39,025,000	-36,715,000	-35,927,000	-35,040,000	-41,349,000	-38,473,000	-24,084,000																																	-199,000							-1,151,000
total stockholders’ equity	796,320,000	911,451,000	849,173,000	882,300,000	820,836,000	906,860,000	878,851,000	905,368,000	959,959,000	943,319,000	893,660,000	864,616,000	817,997,000	775,979,000	729,009,000	770,423,000	749,424,000	730,775,000	698,549,000	677,080,000	731,670,000	719,152,000	667,923,000	608,569,000	587,109,000	574,580,000	583,754,000	590,966,000	667,868,000	643,129,000	701,338,000	674,059,000	752,429,000	822,807,000	801,253,000	772,770,000	739,610,000	770,897,000	749,114,000		721,565,000	719,552,000	776,880,000	791,647,000	826,122,000	833,908,000	820,718,000	815,072,000	837,888,000	825,220,000	796,473,000	774,378,000	769,182,000	779,158,000	771,966,000	757,467,000	732,631,000	705,233,000	678,277,000	712,456,000	686,136,000	648,524,000	594,392,000	564,956,000	593,124,000	573,080,000	579,432,000	563,853,000	539,884,000	515,788,000	496,815,000	493,930,000				476,555,000	479,648,000	453,344,000	456,990,000	461,835,000	441,650,000	418,973,000	387,250,000	372,569,000
total liabilities and stockholders’ equity	2,395,925,000	2,490,890,000	2,442,156,000	2,462,094,000	2,450,948,000	2,531,270,000	2,525,224,000	2,540,977,000	2,195,591,000	2,200,428,000	2,011,275,000	1,962,258,000	1,934,825,000	1,878,066,000	1,865,112,000	1,820,526,000	1,859,734,000	1,831,376,000	1,801,497,000	1,794,187,000	1,819,923,000	1,318,068,000	1,418,174,000	1,433,173,000	1,267,110,000	1,237,749,000	1,190,541,000	1,259,610,000	1,274,767,000	1,227,637,000	1,265,711,000	1,241,168,000	1,237,339,000	1,311,714,000	1,271,163,000	1,251,382,000	1,238,709,000	1,306,421,000	1,334,826,000	1,317,391,000	1,319,128,000	1,336,422,000	1,418,944,000	1,427,411,000	1,485,417,000	1,474,145,000	1,474,545,000	1,476,731,000	1,514,178,000	1,487,893,000	1,484,246,000	1,479,630,000	1,461,917,000	1,474,373,000	1,454,555,000	928,123,000	911,135,000	847,773,000	823,722,000	853,406,000	833,264,000	783,388,000	737,737,000	697,595,000	760,660,000	702,212,000	714,294,000	691,943,000	649,693,000	622,348,000	600,710,000	608,229,000				578,104,000	572,735,000	549,868,000	561,432,000	568,234,000	546,543,000	523,136,000	499,223,000	485,862,000
intangible assets, less accumulated amortization of 352,122 as of december 27, 2025 and 316,313 as of march 29, 2025		419,734,000
intangible assets, less accumulated amortization of 339,593 as of september 27, 2025 and 316,313 as of march 29, 2025			428,357,000
intangible assets, less accumulated amortization of 330,652 at june 28, 2025 and 316,313 at march 29, 2025				450,634,000
intangible assets, less accumulated amortization of 316,313 at march 29, 2025 and 455,213 at march 30, 2024					455,743,000
intangible assets, less accumulated amortization of 311,596 at december 28, 2024 and 455,213 at march 30, 2024						465,615,000
intangible assets, less accumulated amortization of 484,517 at september 28, 2024 and 455,213 at march 30, 2024							487,837,000
intangible assets, less accumulated amortization of 469,659 at june 29, 2024 and 455,213 at march 30, 2024								494,935,000
intangible assets, less accumulated amortization of 455,213 at march 30, 2024 and 417,422 at april 1, 2023									406,117,000
intangible assets, less accumulated amortization of 442,810 at december 30, 2023 and 417,422 at april 1, 2023										429,270,000
intangible assets, less accumulated amortization of 433,092 at september 30, 2023 and 417,422 at april 1, 2023											250,504,000
intangible assets, less accumulated amortization of 427,521 at july 1, 2023 and 417,422 at april 1, 2023												268,146,000
intangible assets, less accumulated amortization of 417,422 at april 1, 2023 and 376,552 at april 2, 2022													275,771,000
intangible assets, less accumulated amortization of 407,039 at december 31, 2022 and 376,552 at april 2, 2022														284,383,000
intangible assets, less accumulated amortization of 395,822 at october 1, 2022 and 376,552 at april 2, 2022															292,595,000
intangible assets, less accumulated amortization of 386,235 at july 2, 2022 and 376,552 at april 2, 2022																302,710,000
intangible assets, less accumulated amortization of 376,552 at april 2, 2022 and 320,640 at april 3, 2021																	310,261,000
intangible assets, less accumulated amortization of 362,637 at january 1, 2022 and 320,640 at april 3, 2021																		323,951,000
other liabilities																		121,126,000	119,701,000	127,811,000		99,223,000	93,270,000	91,595,000		98,003,000	86,835,000	83,973,000		79,693,000	69,514,000	65,731,000		68,151,000	67,282,000	68,324,000		59,546,000	64,294,000	71,040,000				52,342,000		58,980,000	60,041,000	57,153,000	59,710,000	57,264,000	60,617,000	60,601,000	57,351,000	62,557,000	60,927,000	51,972,000	56,835,000	45,342,000	45,703,000	44,321,000	46,256,000	45,543,000	44,281,000	44,427,000		34,581,000	41,395,000	40,247,000		32,466,000	29,126,000	39,088,000				33,839,000	26,944,000				19,141,000
intangible assets, less accumulated amortization of 348,336 at october 2, 2021 and 320,640 at april 3, 2021																			337,249,000
intangible assets, less accumulated amortization of 335,060 at july 3, 2021 and 320,640 at april 3, 2021																				353,688,000
intangible assets, less accumulated amortization of 320,640 at april 3, 2021 and 296,942 at march 28, 2020																					365,483,000
intangible assets, less accumulated amortization of 309,951 at december 26, 2020 and 296,942 at march 28, 2020																						119,716,000
intangible assets, less accumulated amortization of 299,450 at september 26, 2020 and 296,942 at march 28, 2020																							127,210,000
intangible assets, less accumulated amortization of 299,039 at june 27, 2020 and 296,942 at march 28, 2020																								137,520,000
intangible assets, less accumulated amortization of 296,942 at march 28, 2020 and 263,479 at march 30, 2019																									133,106,000
intangible assets, less accumulated amortization of 287,526 at december 28, 2019 and 263,479 at march 30, 2019																										107,307,000
intangible assets, less accumulated amortization of 279,154 at september 28, 2019 and 263,479 at march 30, 2019																											113,540,000
intangible assets, less accumulated amortization of 271,769 at june 29, 2019 and 263,479 at march 30, 2019																												120,340,000
intangible assets, less accumulated amortization of 263,479 at march 30, 2019 and 249,278 at march 31, 2018																													127,693,000
intangible assets, less accumulated amortization of 272,370 at december 29, 2018 and 249,278 at march 31, 2018																														134,724,000
intangible assets, less accumulated amortization of 264,742 at september 29, 2018 and 249,278 at march 31, 2018																															141,483,000
intangible assets, less accumulated amortization of 256,675 at june 30, 2018 and 249,278 at march 31, 2018																																148,730,000
intangible assets, less accumulated amortization of 249,278 at march 31, 2018 and 215,772 at april 1, 2017																																	156,589,000
intangible assets, less accumulated amortization of 240,851 at december 30, 2017 and 215,772 at april 1, 2017																																		163,946,000
intangible assets, less accumulated amortization of 232,714 at september 30, 2017 and 215,772 at april 1, 2017																																			169,379,000
intangible assets, less accumulated amortization of 224,302 at july 1, 2017 and 215,772 at april 1, 2017																																				173,420,000
deferred tax asset, long-term																																				4,399,000		7,575,000	7,942,000																														3,007,000
deferred tax liability, long-term																																				12,818,000		24,463,000	22,188,000																										13,535,000				3,129,000
intangible assets, less accumulated amortization of 215,772 at april 1, 2017 and 190,816 at april 2, 2016																																					177,540,000
deferred tax asset, long term																																					3,988,000			7,572,000	7,055,000	5,290,000	3,053,000	3,080,000	3,023,000	1,031,000	1,071,000	1,119,000		1,751,000	1,751,000	1,751,000	1,751,000	733,000	1,974,000	656,000	23,000	757,000	1,353,000	1,357,000	1,291,000	937,000	1,372,000	5,433,000		2,814,000	2,551,000	3,765,000		14,784,000	9,894,000	9,954,000				5,200,000	4,513,000	3,759,000	3,181,000	2,153,000	1,237,000	224,000	207,000	219,000
long-term deferred tax liability																																					12,114,000			21,416,000	21,377,000	33,510,000	34,781,000	34,354,000	32,097,000	25,871,000	26,911,000	28,366,000	29,664,000	29,664,000	29,265,000	29,961,000	29,552,000	25,497,000	26,513,000	24,356,000	23,332,000	16,775,000	18,005,000	18,386,000	18,669,000	11,872,000	12,681,000	13,512,000		3,658,000	3,702,000	5,871,000		7,655,000	3,253,000	3,253,000
intangible assets, less accumulated amortization of 206,444 at december 31, 2016 and 190,816 at april 2, 2016																																						185,427,000
intangible assets, less accumulated amortization of 199,110 at october 1, 2016 and 190,816 at april 2, 2016																																							192,451,000
intangible assets, less accumulated amortization of 190,638 at july 2, 2016 and 190,816 at april 2, 2016																																								198,121,000
total stockholders’ equity:																																								715,560,000
intangible assets, less accumulated amortization of 190,816 at april 2, 2016 and 133,175 at march 28, 2015																																									204,458,000
intangible assets, less accumulated amortization of 177,424 at december 26, 2015 and 133,175 at march 28, 2015																																										214,809,000
accrued taxes																																										1,791,000	2,209,000	2,780,000	3,819,000
intangible assets, less accumulated amortization of 150,318 at september 26, 2015 and 133,175 at march 28, 2015																																											237,685,000
net property, plant and equipment																																												328,882,000		323,491,000	311,999,000	294,100,000	271,437,000	260,105,000	258,267,000	254,976,000	256,953,000	263,128,000	239,160,000	166,240,000	161,657,000	157,703,000	156,866,000	156,978,000	155,528,000	156,116,000	157,297,000	157,365,000	153,298,000	154,006,000	152,954,000	150,387,000	137,807,000	129,470,000	124,905,000	119,078,000				95,330,000	90,775,000	84,050,000	80,757,000	79,920,000	75,266,000	70,294,000	67,075,000	67,910,000
intangible assets, less accumulated amortization of 141,945 at june 27, 2015 and 133,175 at march 28, 2015																																												241,873,000
intangible assets																																													244,588,000				271,159,000				264,388,000
accumulated other comprehensive income																																													-21,724,000	-7,575,000	66,000	565,000	1,410,000	4,931,000	3,932,000	5,174,000	5,433,000	6,890,000	4,556,000	5,241,000	9,110,000	9,118,000	8,785,000	11,539,000	9,541,000	5,721,000	5,166,000	2,028,000	5,905,000	5,595,000	4,061,000	3,786,000	3,283,000	2,922,000	7,776,000	8,801,000				1,015,000
intangible assets, less accumulated amortization of 125,642 at december 27, 2014 and 101,694 at march 29, 2014																																														251,221,000
accrued income taxes																																														2,754,000	3,347,000	2,076,000	3,113,000	3,247,000	4,403,000	5,322,000	4,053,000	6,632,000	7,430,000	8,080,000	8,075,000	7,545,000	5,361,000	6,082,000	6,033,000	4,820,000	4,679,000	2,337,000	5,092,000	5,536,000	7,135,000	1,788,000	2,833,000	6,466,000	8,008,000	7,090,000				1,032,000	1,163,000	9,473,000	7,602,000	15,050,000	10,264,000	9,704,000	9,509,000	15,893,000
intangible assets, less accumulated amortization of 117,770 at september 27, 2014 and 101,694 at march 29, 2014																																															257,544,000
intangible assets, less accumulated amortization of 110,030 at june 28, 2014 and 101,694 at march 29, 2014																																																264,560,000
other assets:
total other assets																																																	619,765,000	624,456,000	633,898,000	633,282,000	607,954,000	612,363,000	638,595,000	221,696,000	222,349,000	222,897,000	225,756,000	228,159,000	228,905,000	221,255,000	218,218,000	216,714,000	221,219,000	154,099,000	155,215,000	145,402,000	129,493,000	138,986,000	134,337,000	135,341,000				79,708,000	78,289,000	67,305,000	66,870,000	55,037,000	52,873,000	50,744,000	53,088,000	53,087,000
property, plant and equipment:
total property, plant and equipment																																																		676,388,000	662,735,000	641,476,000	632,720,000	619,501,000	590,946,000	518,155,000	510,534,000	496,508,000	490,069,000	485,118,000	475,684,000	474,180,000	469,499,000	451,392,000	443,101,000	441,049,000	434,539,000	420,652,000	397,863,000	386,094,000	378,816,000	371,233,000				320,756,000	310,854,000	301,723,000	300,862,000	294,041,000	283,476,000	277,863,000	272,908,000	270,154,000
less: accumulated depreciation																																																		-416,283,000	-404,468,000	-386,500,000	-375,767,000	-356,373,000	-351,786,000	-351,915,000	-348,877,000	-338,805,000	-333,203,000	-328,140,000	-320,156,000	-318,064,000	-312,202,000	-294,027,000		-287,043,000	-281,585,000	-270,265,000				252,155,000				225,426,000	220,079,000			214,121,000	208,210,000	207,569,000	205,833,000	202,244,000
intangible assets, less accumulated amortization of 94,341 at december 28, 2013 and 72,393 at march 30, 2013																																																		275,287,000
intangible assets, less amortization of 86,608 at september 28, 2013 and 72,393 at march 30, 2013																																																			277,065,000
intangible assets, less amortization of 79,306 at june 29, 2013 and 72,393 at march 30, 2013																																																				279,098,000
land, building and building improvements																																																					82,898,000	80,242,000			59,816,000			52,544,000	52,359,000	51,945,000	50,969,000	49,292,000		48,249,000	45,009,000	43,611,000		42,487,000	43,631,000	43,765,000				46,266,000	41,649,000				39,570,000
plant equipment and machinery																																																					205,698,000	196,869,000	250,777,000	137,877,000	136,057,000	135,268,000	132,124,000	132,404,000	128,612,000	128,691,000	126,351,000	121,337,000	113,534,000	111,022,000	109,384,000	113,373,000	108,572,000	101,232,000	97,491,000	91,811,000				76,798,000	85,140,000				69,729,000
office equipment and information technology																																																					103,235,000	100,955,000	32,423,000	94,982,000	88,185,000	85,894,000	85,347,000	84,530,000	83,258,000	82,264,000	80,824,000	76,173,000	74,008,000	72,067,000	71,242,000	61,744,000	52,461,000	52,844,000	53,222,000	53,348,000				43,427,000	34,320,000				40,759,000
haemonetics equipment																																																					240,889,000	241,435,000	228,328,000	229,763,000	226,476,000	220,187,000	217,471,000	215,640,000	211,455,000	211,280,000	211,355,000	204,590,000	206,267,000	209,711,000	208,904,000	201,924,000	194,290,000	189,531,000	184,472,000	182,309,000				154,265,000	149,745,000				133,418,000
commitments and contingencies
intangible assets, less amortization of 71,102 at december 29, 2012 and 54,973 at march 31, 2012																																																						273,695,000
land, building, and building improvements																																																							79,418,000	55,533,000		55,159,000	55,127,000
intangible assets, less amortization of 64,378 at september 29, 2012 and 54,973 at march 31, 2012																																																							297,972,000
common stock, .01 par value...																																																							257,000	256,000		251,000	249,000						255,000				256,000									264,000	269,000
intangible assets, less amortization of 57,710 at june 30, 2012 and 54,973 at march 31, 2012																																																								94,913,000
intangible assets, less amortization of 54,973 at march 31, 2012 and 43,827 at april 2, 2011																																																									96,549,000
intangible assets, less amortization of 52,033 at december 31, 2011 and 43,827 at april 2, 2011																																																										97,060,000
intangible assets, less amortization of 49,320 at october 1, 2011 and 43,827 at april 2, 2011																																																											98,847,000
intangible assets, less amortization of 46,707 at july 2, 2011 and 43,827 at april 2, 2011																																																												100,892,000
intangible assets, less amortization of 43,827 at april 2, 2011 and 32,693 at april 3, 2010																																																													101,789,000
intangible assets, less amortization of 42,135 at january 1, 2011 and 32,693 at april 3, 2010																																																														99,649,000
intangible assets, less amortization of 38,977 at october 2, 2010 and 32,693 at april 3, 2010																																																															94,544,000
intangible assets, less amortization of 35,845 at july 3, 2010 and 32,693 at april 3, 2010																																																																84,214,000
deferred tax assets																																																																	10,985,000
land, building and building & leasehold improvements																																																																	49,292,000				42,540,000
less accumulated depreciation																																																																	-289,803,000				-260,056,000
other intangibles, less accumulated amortization of 32,693 in 2010 and 25,508 in 2009																																																																	86,102,000
deferred tax assets, long-term																																																																	4,910,000
other accrued liabilities																																																																	50,639,000				37,895,000									20,451,000	25,298,000	20,837,000		18,987,000	23,078,000	19,157,000
intangible assets, less amortization of 31,088 at december 26, 2009 and 25,508 at march 28, 2009																																																																		74,496,000
other intangibles, less amortization of 29,202 at september 26, 2009 and 25,508 at march 28, 2009																																																																			74,872,000
other intangibles, less amortization of 27,349 at june 27, 2009 and 25,508 at march 28, 2009																																																																				72,008,000
other intangibles, less accumulated amortization of 25,508 in 2009 and 19,821 in 2008																																																																					65,261,000
other intangibles, less amortization of 24,078 at december 27, 2008 and 19,821 at march 29, 2008																																																																						63,936,000
other intangibles, less amortization of 22,801 at september 27, 2008 and 19,821 at march 29, 2008																																																																							65,095,000
other intangibles, less amortization of 21,380 at june 28, 2008 and 19,821 at march 29, 2008																																																																								65,520,000
liabilities and stockholders' equity
stockholders' equity:
total stockholders' equity
accrued vat
authorized—150,000,000 shares;
issued and outstanding—25,621,738 shares at december 29, 2007 and 26,516,979 shares at march 31, 2007
accumulated other comprehensive income/
issued and outstanding—25,411,578 shares at september 29, 2007 and 26,516,979 shares at march 31, 2007
other intangibles, less amortization of 18,200 at june 30, 2007 and 17,284 at march 31, 2007																																																																												35,059,000
issued and outstanding — 26,473,061 shares at june 30, 2007 and 26,516,979 shares at march 1, 2007																																																																												262,000
other intangibles, less amortization of 17,284 in 2007 and 14,446 in 2006																																																																													33,857,000
issued—26,516,979 shares in 2007 and 26,829,249 shares in 2006																																																																													265,000
other intangibles, less amortization of 16,460 at december 30, 2006 and 14,447 at april 1, 2006																																																																														25,927,000
other intangibles, less amortization of 15,749 at september 30, 2006 and 14,447 at april 1, 2006																																																																															25,915,000
other intangibles, less amortization of 14,010 as of july 1, 2006 and 14,447 as of april 1, 2006																																																																																23,321,000
other intangibles, less amortization of 14,447 in 2006 and 9,327 in 2005																																																																																	22,945,000
issued—26,829,249 shares in 2006 and 26,177,468 shares in 2005																																																																																	268,000
other intangibles, less amortization of 13,842 as of december 31, 2005 and 9,327 as of april 2, 2005																																																																																		22,632,000
other intangibles, less amortization of 10,386 as of october 1, 2005 and 9,327 as of april 2, 2005																																																																																			24,864,000
other intangibles, less amortization of 9,839 as of july 2, 2005 and 9,327 as of april 2, 2005																																																																																				25,291,000

Cashflow Statements:

Quarterly

Annual

Unit: USD	2026-03-28	2025-12-27	2025-09-27	2025-06-28	2025-03-29	2024-12-28	2024-09-28	2024-06-29	2024-03-30	2023-12-30	2023-09-30	2023-07-01	2023-04-01	2022-12-31	2022-10-01	2022-07-02	2022-04-02	2022-01-01	2021-10-02	2021-07-03	2021-04-03	2020-12-26	2020-09-26	2020-06-27	2020-03-28	2019-12-28	2019-09-28	2019-06-29	2019-03-30	2018-12-29	2018-09-29	2018-06-30	2018-03-31	2017-12-30	2017-09-30	2017-07-01	2017-04-01	2016-12-31	2016-10-01	2016-07-02	2016-04-02	2015-12-26	2015-09-26	2015-06-27	2015-03-28	2014-12-27	2014-09-27	2014-06-28	2014-03-29	2013-12-28	2013-09-28	2013-06-29	2013-03-30	2012-12-29	2012-09-29	2012-06-30	2012-03-31	2011-12-31	2011-10-01	2011-07-02	2011-04-02	2011-01-01	2010-10-02	2010-07-03	2010-04-03	2009-12-26	2009-09-26	2009-06-27	2009-03-28	2008-12-27	2008-09-27	2008-06-28	2007-06-30	2007-03-31	2006-12-30	2006-09-30	2006-07-01	2006-04-01	2005-12-31	2005-10-01	2005-07-02

cash flows from operating activities:
net income	-20,147,000	44,740,000	38,684,000	34,031,000	57,981,000	37,494,000	33,831,000	38,373,000	20,367,000	31,241,000	24,908,000	41,042,000	29,383,000	32,944,000	33,197,000	19,877,000	9,741,000	23,232,000	14,856,000	-4,454,000	-11,041,000	31,882,000	48,101,000	10,527,000	17,624,000	29,895,000			20,835,000	18,277,000	18,726,000	-2,819,000	11,880,000	-6,547,000	20,102,000	20,137,000	-51,140,000	15,393,000			-8,735,000	-59,440,000			-2,930,000	15,988,000			10,184,000	16,290,000	16,548,000	-7,874,000	12,561,000	9,904,000	6,548,000	9,787,000	17,806,000	18,252,000	13,881,000	16,947,000	20,988,000	19,735,000	21,339,000	17,918,000	3,961,000	18,286,000	18,050,000	18,073,000	13,939,000	16,217,000	14,807,000	14,341,000	12,677,000	19,785,000	16,902,000	1,114,000	11,308,000	17,158,000	28,089,000	10,945,000	12,884,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	27,319,000	27,385,000	28,255,000	28,758,000	28,208,000	29,025,000	29,217,000	29,136,000	27,639,000	23,531,000	23,013,000	23,032,000	23,854,000	23,570,000	23,436,000	22,447,000	24,813,000	24,367,000	23,534,000	25,033,000	21,910,000	20,774,000	20,879,000	20,724,000	28,765,000	27,055,000	27,032,000	27,437,000	29,781,000	27,945,000	25,277,000	26,415,000	22,980,000	22,281,000	22,197,000	21,789,000	22,202,000	22,278,000	22,709,000	22,544,000	22,190,000	22,723,000	22,743,000	22,255,000	22,162,000	22,266,000	21,114,000	20,511,000	22,677,000	20,807,000	19,899,000	18,357,000	18,740,000	18,131,000	17,430,000	11,180,000	12,710,000	12,637,000	12,631,000	11,988,000	11,120,000	12,335,000	12,280,000	12,410,000	11,455,000	11,082,000	10,641,000	10,058,000	6,621,000	11,758,000	10,097,000	7,986,000	7,180,000	6,478,000	6,906,000	7,378,000	6,742,000	6,665,000	6,200,000	6,954,000	5,331,000
amortization of fair value inventory step-up	0	1,323,000	2,055,000	2,436,000	2,637,000	3,341,000	3,739,000	5,239,000										0	0	5,295,000
share-based compensation expense	9,127,000	7,799,000	7,589,000	9,312,000	6,937,000	8,214,000	6,857,000	7,628,000	7,420,000	7,217,000	6,706,000	6,989,000	7,058,000	7,491,000	5,735,000	5,299,000	5,097,000	6,455,000	5,979,000	6,828,000	7,110,000	6,287,000	5,952,000	6,167,000	5,399,000	5,325,000	5,000,000	4,730,000
impairment of intangible assets	77,246,000	716,000			0	0
gain on repurchase of convertible senior notes					0	0	0	-12,600,000
gains on sales of property, plant and equipment	-178,000	-218,000	-75,000	-243,000	-1,126,000	-160,000	-121,000	-14,291,000
remeasurement of contingent consideration
deferred income taxes	-20,453,000	-2,062,000	-725,000	-3,231,000
other non-cash operating activities	5,975,000	2,072,000	865,000	1,814,000	1,864,000	3,591,000	6,450,000	-1,927,000	2,563,000	-594,000	-2,518,000	682,000	5,080,000	2,232,000	-2,788,000	1,602,000	4,489,000	242,000	1,216,000	-355,000	-1,200,000	989,000	296,000	66,000	-3,179,000	1,805,000	90,000	50,000	-1,454,000	-239,000	1,258,000	19,000	1,294,000	86,000	-346,000	658,000	-25,000	452,000	176,000	257,000
change in operating assets and liabilities:
change in accounts receivable	-22,237,000	11,058,000	-7,259,000	3,557,000	10,335,000	-1,771,000	-9,578,000	7,970,000	3,550,000	-30,600,000	1,847,000	1,010,000	-51,000	-7,327,000	-27,401,000	10,358,000	-6,238,000	-14,162,000	-9,232,000	-5,342,000	25,533,000	-3,803,000	-2,676,000	25,067,000	5,056,000	6,001,000	-14,712,000	22,518,000	-18,312,000	-6,426,000	-11,749,000	-1,577,000	-3,117,000	-2,535,000	8,536,000	2,203,000	-723,000	-2,929,000	-1,432,000	8,239,000	-6,720,000	-3,851,000	-6,331,000	6,574,000
change in inventories	8,462,000	13,841,000	21,762,000	3,296,000	925,000	-12,547,000	-13,252,000	-39,830,000	-19,340,000	-10,067,000	-1,258,000	-29,396,000	-3,752,000	-1,484,000	20,750,000	15,240,000	12,718,000	17,064,000	3,078,000	-8,553,000	-5,181,000	4,461,000	-13,632,000	-24,557,000	-16,470,000	-8,812,000	-22,025,000	-37,414,000	-27,698,000	-7,712,000	11,146,000	-15,058,000	-3,075,000	10,176,000	5,867,000	1,417,000	12,408,000	-1,299,000	-8,940,000	-3,721,000	5,628,000	3,758,000	3,228,000	-718,000
change in prepaid income taxes	-5,886,000	-1,784,000	-210,000	3,346,000	2,864,000	1,075,000	-6,936,000	3,223,000	-2,713,000	2,636,000	-2,501,000	1,595,000	-282,000	-175,000	27,000	2,118,000	-1,530,000	1,923,000	356,000	2,121,000	-5,003,000	1,816,000	2,909,000	-3,544,000				-3,228,000	-3,593,000	348,000	-421,000	72,000	631,000	29,000	-41,000	817,000	527,000	1,192,000	608,000	-932,000	-1,648,000	1,179,000	187,000	-369,000
change in other assets and other liabilities	-6,730,000	-4,610,000	-5,903,000	-17,785,000	9,261,000	-20,603,000	-4,051,000	-9,839,000	-18,427,000	-5,328,000	-305,000	-9,986,000	-11,670,000	-2,940,000	-1,645,000	-6,079,000	-9,012,000	-5,168,000	-2,098,000	1,256,000	-7,337,000	785,000	1,037,000	865,000	6,226,000	3,102,000	-3,996,000	-8,208,000	-11,606,000	8,005,000	5,309,000	-1,214,000	-77,000	13,827,000	-5,078,000	8,998,000	-17,257,000	-3,832,000	1,710,000	1,126,000	-3,501,000	8,334,000	-5,411,000	3,699,000
change in accounts payable and accrued expenses	20,322,000	-6,696,000	17,699,000	-47,896,000	17,608,000	3,309,000	3,980,000	-44,105,000	49,524,000	-23,704,000	33,689,000	-14,927,000	23,642,000	7,307,000	36,048,000	-27,181,000	27,040,000	6,051,000	3,850,000	-29,299,000	-34,904,000	3,252,000	453,000	-25,223,000	282,000	10,881,000	8,341,000	-36,812,000	11,808,000	10,513,000	2,328,000	-6,913,000	23,343,000	24,873,000	5,050,000	-11,865,000	739,000	14,164,000	-2,089,000	8,258,000	9,732,000	-12,898,000	-1,891,000	-25,182,000
net cash from operating activities	70,941,000	93,564,000	111,321,000	17,395,000	116,557,000	43,766,000	48,823,000	-27,421,000	64,081,000	-540,000	99,124,000	19,086,000	79,611,000	64,415,000	87,039,000	41,993,000	68,050,000	62,433,000	43,460,000	-1,680,000	1,547,000	66,291,000	29,155,000	11,812,000	46,406,000	79,282,000	29,901,000	2,628,000	20,638,000	58,164,000	57,357,000	23,122,000	57,627,000	65,395,000	58,903,000	38,425,000	34,577,000	55,201,000	39,265,000	30,695,000	53,253,000	31,851,000	27,511,000	9,250,000	55,305,000	26,893,000	31,242,000	13,738,000	51,471,000	45,291,000	29,360,000	13,402,000	27,542,000	23,965,000	33,014,000	553,000	33,975,000	28,804,000	25,408,000	27,131,000	32,139,000	47,030,000	30,760,000	13,526,000	36,687,000	32,502,000	35,773,000	25,706,000					14,181,000		25,968,000	15,990,000	17,509,000				11,759,000
cash flows from investing activities:
capital expenditures	-17,661,000	-6,349,000	-5,016,000	-3,754,000	-15,643,000	-8,546,000	-9,433,000	-5,656,000	-9,685,000	-22,294,000	-24,654,000	-9,663,000	-11,919,000	-16,848,000	-35,957,000	-45,467,000	-35,115,000	-26,663,000	-20,812,000	-13,919,000	-11,632,000	-9,373,000	-8,339,000	-7,696,000	-10,646,000	-20,390,000	-9,473,000	-8,249,000	-13,716,000	-29,243,000	-48,488,000	-27,514,000	-19,103,000	-26,571,000	-15,404,000	-13,721,000	-15,618,000	-18,893,000	-19,145,000	-22,479,000	-28,534,000	-23,741,000	0	0	0	0	0	0	0	0	0	0	0	0	0	-8,441,000	0	0	0	0	0	0	0	0	0	0	0	0					0		0	0	0				0
free cash flows	53,280,000	87,215,000	106,305,000	13,641,000	100,914,000	35,220,000	39,390,000	-33,077,000	54,396,000	-22,834,000	74,470,000	9,423,000	67,692,000	47,567,000	51,082,000	-3,474,000	32,935,000	35,770,000	22,648,000	-15,599,000	-10,085,000	56,918,000	20,816,000	4,116,000	35,760,000	58,892,000	20,428,000	-5,621,000	6,922,000	28,921,000	8,869,000	-4,392,000	38,524,000	38,824,000	43,499,000	24,704,000	18,959,000	36,308,000	20,120,000	8,216,000	24,719,000	8,110,000	27,511,000	9,250,000	55,305,000	26,893,000	31,242,000	13,738,000	51,471,000	45,291,000	29,360,000	13,402,000	27,542,000	23,965,000	33,014,000	-7,888,000	33,975,000	28,804,000	25,408,000	27,131,000	32,139,000	47,030,000	30,760,000	13,526,000	36,687,000	32,502,000	35,773,000	25,706,000					14,181,000		25,968,000	15,990,000	17,509,000				11,759,000
proceeds from divestiture and sale of assets
proceeds from sale of property, plant and equipment	526,000	432,000	120,000	297,000	2,451,000	251,000	189,000	20,362,000	551,000	338,000	519,000	402,000	-6,087,000	158,000	7,039,000	498,000	603,000	559,000	292,000	568,000	730,000	183,000	496,000	406,000	511,000	524,000	15,437,000	302,000	499,000	1,658,000	406,000	250,000	1,131,000	281,000	365,000	981,000	1,049,000	1,576,000	110,000	87,000	240,000	104,000	177,000	116,000	65,000	10,000	313,000	64,000	291,000	-445,000	73,000	569,000	678,000	935,000	103,000	252,000	485,000	387,000	111,000	19,000	1,134,000	72,000	151,000	111,000	1,175,000	227,000	182,000	201,000	-139,000	25,000	21,000	2,476,000	1,305,000	255,000	834,000	730,000	1,024,000	1,734,000	1,037,000	1,059,000	1,859,000
non-cash transfers from inventory to property, plant and equipment for haemonetics equipment	-9,298,000	-13,444,000	-17,689,000	-11,460,000	-8,463,000	-5,895,000	-2,543,000	-4,211,000
acquisitions									0
other investments	0	-10,105,000	-7,883,000	-18,083,000				-541,000	-5,422,000	-3,129,000	-1,000,000	-6,000,000	0	-19,810,000	-3,000,000	-10,395,000
net cash from investing activities	-86,613,000	-29,466,000	-30,468,000	-33,000,000	18,040,000	-17,371,000	-23,367,000	-139,197,000	-13,056,000	-268,937,000	-25,135,000	-15,261,000	-18,006,000	-36,500,000	-31,068,000	-58,214,000	-34,512,000	-15,462,000	-20,520,000	-15,851,000	-429,100,000	-9,581,000	37,135,000	-23,896,000	-45,135,000	-19,866,000	5,964,000	1,861,000	-13,217,000	-27,585,000	-48,082,000	-27,264,000	-17,972,000	-26,290,000	-15,039,000	-3,740,000	-14,569,000	-17,317,000	-19,035,000	-22,392,000	-28,294,000	-23,637,000	-25,707,000	-27,130,000	-21,625,000	-29,648,000	-33,474,000	-37,021,000	-30,808,000	-15,631,000	-23,744,000	-35,647,000	-11,856,000	-14,318,000	-561,032,000	-9,189,000	-15,754,000	-12,729,000	-11,931,000	-11,782,000	-10,549,000	-17,183,000	-8,713,000	-15,113,000	-68,304,000	-11,770,000	-24,338,000	-27,923,000													-4,617,000
cash flows from financing activities:
proceeds from issuance of convertible notes					0	0	0	700,000,000
repayment and repurchase of convertible notes
purchase of capped call related to convertible notes					0	0	0	-88,200,000
term loan borrowings					0	0	0	250,000,000					0	0															0	0	0	347,780,000																					0
term loan redemption					0	0	0	-262,500,000					0	0
repayment of term loan borrowings	-1,562,000	-1,563,000	-1,562,000	-1,563,000	-1,563,000	-1,562,000	0	-1,563,000	-3,500,000	-3,500,000	-3,500,000	-1,750,000	-1,750,000	-1,750,000	-1,750,000	-4,375,000	-4,375,000	-4,375,000	-4,375,000	-4,375,000	-8,750,000	-4,375,000	-4,375,000	-4,375,000	-4,375,000	-4,375,000	0	-4,375,000	-8,750,000	0	-4,375,000	-253,728,000	-16,600,000	-16,599,000	-16,599,000	-11,856,000	-11,856,000	-11,857,000	-11,856,000	-7,114,000	-14,228,000				0	0	0	-8,531,000	-8,532,000	-8,531,000
proceeds from revolving facility									0				0	0
payments on revolving facility					0	0	0	-50,000,000					0
debt issuance costs					0	0	0	-23,135,000					0	0																																							-6,000	1,000
proceeds from employee stock programs
cash used to net share settle employee equity awards	-46,000	-160,000	-14,000	-4,781,000	0	-449,000	-44,000	-9,750,000	0	-43,000	-4,359,000	-1,483,000
share repurchases	-100,000,000	0			-150,000,000	0							0	0											0	-50,000,000	-50,000,000	-75,000,000	0	-80,000,000	0	-80,000,000									0	0	-21,952,000	-39,032,000		-4,931,000	-7,304,000	-26,466,000
other financing activities	-13,000	-14,000	-39,000	-36,000	-27,000	-149,000	-11,000	-62,000	-108,000	54,000	-5,000	-14,000
net cash from financing activities	-101,499,000	2,033,000	-76,552,000	-2,442,000	-151,450,000	1,380,000	-74,804,000	333,692,000	-63,502,000	109,429,000	-7,172,000	-598,000	-1,603,000	-49,680,000	-25,686,000	-23,395,000		-2,035,000	-3,315,000	-1,634,000		-149,940,000	-64,318,000	148,951,000	11,372,000	-46,153,000	-112,517,000	16,090,000	6,995,000	-76,207,000	-79,000	18,663,000	-112,653,000	8,306,000	-12,747,000	-3,549,000	-10,449,000	-45,389,000	411,000	-4,986,000	-15,653,000	-2,990,000	-14,209,000	-29,772,000	2,518,000	-222,000	-6,645,000	-28,811,000	-6,032,000	-10,800,000	-13,372,000	9,504,000	-29,185,000			16,227,000	5,244,000	6,039,000	-46,220,000	4,467,000	4,086,000	25,131,000	7,636,000	-54,937,000	4,833,000	-30,710,000	-6,937,000	18,844,000									476,000				4,927,000
effect of exchange rates on cash and cash equivalents	-756,000	810,000	-773,000	4,182,000	2,770,000	-6,212,000	4,202,000	-1,445,000	-2,701,000	3,021,000	-1,531,000	-1,974,000	462,000	4,567,000	-4,033,000	-4,932,000	-2,154,000	-479,000	-667,000	322,000	-1,903,000	3,063,000	1,472,000	1,547,000	-1,749,000	1,124,000	-1,552,000	304,000	64,000	736,000	-1,539,000	-2,584,000	1,576,000	558,000	766,000	1,039,000	366,000	-1,726,000	-19,000	-192,000	650,000	-304,000	448,000	-806,000	-736,000	-1,794,000	-1,095,000	-432,000	-8,000	-162,000	576,000	-51,000	-562,000	257,000	437,000	-405,000	24,000	-163,000	-727,000	368,000	1,493,000	-489,000	1,899,000	-1,571,000	-647,000	649,000	2,000	474,000					1,266,000	141,000	565,000	299,000	662,000				183,000
net change in cash and cash equivalents	-117,927,000	66,941,000	3,528,000	-13,865,000	-14,083,000	21,563,000	-45,146,000	165,629,000	-15,178,000	-157,027,000	65,286,000	1,253,000	60,464,000	-17,198,000	26,252,000	-44,548,000	22,619,000	44,457,000	18,958,000	-18,843,000	3,303,000	-90,167,000	3,444,000	138,414,000	10,894,000	14,387,000	-78,204,000	20,883,000	14,480,000	-44,892,000	7,657,000	11,937,000	-71,422,000	47,969,000	31,883,000	32,175,000	9,925,000	-9,231,000	20,622,000	3,125,000	9,956,000	4,920,000	-11,957,000	-48,458,000
cash and cash equivalents at beginning of year																																																				179,120,000	0	0			0	0	0	196,707,000	0	0	0	141,562,000	0	0	0	156,721,000	0	0	0	133,553,000	229,227,000			0	250,667,000	0	0	0	185,815,000
cash and cash equivalents at end of year
repurchase of convertible senior notes					0	0	0	-185,500,000
proceeds from employee stock purchase plan		2,623,000	0	3,476,000		3,035,000	0	3,441,000	1,000	2,732,000	0	2,871,000	0	1,919,000	0	2,459,000	-1,000	2,000,000	0	2,210,000	1,000	1,868,000	0	2,144,000	1,000	1,538,000	0	1,830,000	0	1,474,000	0	1,780,000	0	1,624,000	0	1,622,000	0	1,581,000	-1,000	1,980,000	1,000	2,077,000	0	2,263,000	0	2,233,000	0	2,530,000	0	2,563,000	0	2,666,000	0	2,037,000	0	2,105,000	1,000
proceeds from exercise of stock options		1,147,000	63,000	462,000		505,000	251,000	961,000	105,000	186,000	692,000	627,000	159,000	160,000	2,192,000	127,000	415,000	354,000	1,069,000	500,000	2,379,000	2,579,000	66,000	1,193,000	935,000	1,666,000	2,411,000	3,635,000	745,000	2,319,000	4,296,000	2,831,000	3,855,000	23,119,000	3,690,000	6,430,000	11,159,000	4,746,000	12,123,000	1,409,000	3,543,000	2,115,000	5,481,000	2,893,000	1,364,000	3,884,000	1,819,000	2,223,000	3,525,000	3,582,000	2,268,000	5,849,000	-825,000	4,693,000	10,403,000	13,246,000	6,399,000
cash and cash equivalents at beginning of period		0	0	306,763,000		0	0	178,800,000		0	0	284,466,000		0	0	259,496,000		0	0	192,305,000		0	0	137,311,000		0	0	169,351,000		0	0	180,169,000		0	0	139,564,000		0	0	115,123,000		0	0	160,662,000		0	0	192,469,000		0
cash and cash equivalents at end of period		66,941,000	3,528,000	292,898,000		21,563,000	-45,146,000	344,429,000		-157,027,000	65,286,000	285,719,000		-17,198,000	26,252,000	214,948,000		44,457,000	18,958,000	173,462,000		-90,167,000	3,444,000	275,725,000		14,387,000	-78,204,000	190,234,000		-44,892,000	7,657,000	192,106,000		47,969,000	31,883,000	171,739,000		-9,231,000	20,622,000	118,248,000		4,920,000	-11,957,000	112,204,000		-4,771,000	-9,972,000	139,943,000		18,698,000	-7,180,000	166,328,000	-14,061,000	6,130,000				21,951,000	-33,470,000	216,891,000	27,169,000	54,489,000	31,582,000	83,467,000	-27,431,000	-9,329,000	4,500,000	173,822,000	31,396,000	13,994,000	-8,956,000	120,287,000	216,056,000	1,520,000	-14,493,000	-17,831,000	260,031,000	21,316,000	19,370,000	11,914,000	198,067,000
contingent consideration payments									0	0	0	-849,000	0	0	0	-21,593,000
supplemental disclosures of cash flow information:
interest paid																				1,482,000	1,754,000	1,433,000	1,857,000	2,780,000	1,806,000	4,479,000	2,725,000	3,535,000	3,624,000	3,659,000	3,472,000	2,361,000	1,979,000	1,916,000	1,943,000	1,825,000	1,792,000	1,940,000	2,046,000	2,072,000	2,305,000	2,044,000	2,094,000	2,068,000	2,226,000	2,091,000	2,169,000	2,011,000	1,969,000	2,251,000	2,321,000	2,401,000	1,890,000	2,332,000	1,604,000	84,000	92,000	102,000	118,000	102,000	114,000	122,000	123,000	128,000	138,000	142,000	153,000	130,000	131,000	139,000	136,000	139,000	353,000	168,000	561,000	160,000	571,000	170,000	774,000	180,000	780,000
income taxes paid																				14,494,000	6,875,000	1,513,000	2,036,000	2,063,000	1,619,000	1,353,000	5,457,000	3,078,000	1,972,000	1,180,000	3,236,000	1,817,000	1,763,000	1,871,000	3,298,000	2,151,000	1,233,000	1,857,000	2,326,000	1,541,000	1,945,000	1,228,000	3,031,000	1,625,000	484,000	2,376,000	6,254,000	2,097,000	-2,600,000	427,000	2,760,000	906,000	4,278,000	1,562,000	4,144,000	3,194,000	4,666,000	3,810,000	901,000	1,387,000	6,674,000	3,054,000	5,291,000	1,650,000	5,998,000	9,161,000	3,380,000	2,980,000	-560,000	12,557,000	3,471,000	3,923,000	2,290,000	14,450,000	116,000	11,688,000	1,250,000	8,026,000	16,527,000	10,870,000	2,666,000
non-cash items:
inventory reserve adjustment						-4,785,000	2,472,000	3,602,000		4,345,000	4,344,000	-1,785,000
deferred tax benefit						-2,417,000											3,014,000	1,101,000				-922,000	-2,530,000	-501,000		2,543,000	-1,981,000	-5,309,000
acquisition, net of cash acquired						0	-1,755,000	-149,151,000
other investing activities						-3,181,000
impairment of assets									0	0			513,000	0	0	94,000	2,809,000	0	0	5,144,000	20,941,000	0	0	1,028,000	2,000	1,876,000	0	48,721,000	0	0	0	21,170,000	2,455,000				71,935,000
gain on divestiture and sale of assets
contingent consideration													0
amortization of deferred financing costs									782,000	783,000	780,000	830,000	872,000
provision for losses on inventory																	-581,000	-394,000	658,000	-544,000
non-cash investing and financing activities:
transfers from inventory to fixed assets for placement of haemonetics equipment									3,610,000	7,648,000	15,541,000	1,982,000	3,190,000	11,494,000	28,430,000	38,022,000	26,415,000	15,246,000	6,936,000	3,203,000	3,409,000	1,675,000	1,839,000	2,364,000	3,774,000	4,925,000	2,807,000	2,973,000	4,245,000	1,000	10,300,000	1,799,000	3,539,000	1,459,000	2,627,000	1,338,000	1,174,000	1,604,000	1,713,000	1,764,000	404,000	3,709,000	2,625,000	2,925,000	1,703,000	1,729,000
proceeds from divestiture														0											0	0	0	9,808,000					0	0	0	9,000,000
acquisition														0	0	-2,850,000		0	0	-2,500,000		0	0	-16,606,000
gain on divestitures and sale of assets
proceeds from divestitures																						-391,000
net decrease in short-term loans																																																								-18,000				-9,000
provision (benefit ) for losses on inventory
gains on divestiture														0
other														-9,000	-10,000	-13,000		-14,000	-9,000	31,000		-12,000	-9,000	-11,000		18,000
amortization of deferred finance costs															-484,000	797,000		795,000	794,000	1,019,000
contingent consideration expense															0	-504,000	189,000	927,000	-429,000	9,774,000																										247,000	235,000	224,000
benefit for losses on inventory																-2,075,000
gains on divestitures and sale of assets																		0	0	-9,603,000		-1,115,000
net increase in short-term loans																					0	-150,000,000	-60,000,000	150,000,000	15,000,000	5,000,000	-65,000,000	90,000,000					92,000	162,000	162,000	255,000	-9,752,000	-39,859,000	145,000	-1,261,000	-4,871,000	219,000	2,544,000	4,380,000	1,200,000	-1,143,000	-901,000	1,687,000	-1,095,000	-8,666,000	3,978,000	262,000		1,340,000			-1,817,000	-463,000			-6,364,000	-3,540,000	4,687,000	-9,936,000
transaction costs paid in connection with convertible notes issuance
net cash (used) in provided by financing activities
tenant improvement allowances excluded from capital expenditures
net (decrease) in short-term loans
gain on divestiture																																	0	0	0	-8,000,000
deferred tax provision
unrealized loss from hedging activities																																					186,000				222,000	-2,157,000			81,000	923,000	450,000	104,000	-479,000	-1,915,000	-510,000	2,776,000		451,000	-402,000	568,000	-1,199,000	285,000	471,000	609,000		429,000	256,000	877,000	210,000	567,000	-626,000	-1,519,000	1,479,000	-1,373,000	1,721,000	1,985,000						-164,000	841,000	1,588,000	-269,000
net cash from (used) in financing activities
provision for losses on accounts receivable and inventory																						1,885,000	-136,000	1,193,000		-389,000	-479,000	-1,378,000	3,105,000	2,671,000	901,000	-352,000	2,125,000	-174,000	-240,000	928,000	-17,000	4,496,000	4,331,000	2,571,000
provision for losses on accounts receivable
gain on sale of assets																										0
right-of-use assets and lease incentive acquired
net loss																												-8,479,000												-10,346,000				-267,000				-3,649,000
adjustments to reconcile net loss to net cash from operating activities:
stock-based compensation expense																														4,782,000	4,582,000	3,379,000	5,665,000	3,161,000	2,856,000	1,343,000	2,542,000
changes in fair value of contingent consideration
other acquisitions and investments																																									0	0	0	-3,000,000						333,000
deferred tax expense																																																																															5,000	0	21,000
tax benefit of exercise of stock options																																													2,825,000	107,000	569,000	285,000	-1,257,000	1,568,000	498,000	840,000	289,000	1,417,000	1,438,000	1,050,000	548,000	458,000			97,000	3,898,000	408,000	538,000	1,463,000	1,030,000	4,000	173,000	680,000	557,000	1,527,000	604,000
payments on long-term real estate mortgage																																									-98,000	-287,000	-282,000	-276,000	-270,000	-265,000	-259,000	-254,000	-249,000	-243,000	-239,000	-233,000	-228,000	-224,000	-217,000	-217,000	67,000	-248,000	-273,000	-361,000	-243,000	-223,000	39,000	-205,000	-189,000	-196,000	-186,000	-183,000													-120,000
asset impairments																																							739,000	1,766,000
stock compensation expense																																							2,395,000	1,840,000			719,000	3,164,000	3,876,000	3,281,000	3,449,000	3,489,000	3,417,000	3,248,000	3,403,000	3,013,000	3,038,000	2,917,000	2,597,000	2,417,000	2,559,000	2,026,000	2,300,000	2,401,000	2,665,000	4,056,000	1,892,000	2,197,000	2,692,000	2,583,000	2,213,000	2,779,000	2,874,000	2,765,000	2,175,000	2,367,000	2,271,000	2,831,000	2,126,000	2,267,000	3,027,000
unrealized gain from hedging activities																																							-767,000	-907,000				-186,000
acquisition of hemerus																																																	0	0	0	-23,124,000
impairment of goodwill and intangible assets
amortization of financing costs																																										213,000	213,000	222,000	216,000	225,000	225,000	347,000	335,000	355,000	388,000	427,000
loss on sale of property, plant and equipment																																										-110,000	164,000	-25,000	-570,000	248,000	-50,000	414,000			111,000	154,000
change in fair value of contingent consideration																																										-4,898,000	88,000	83,000
asset write-down																																										97,000			4,631,000	772,000	213,000	261,000			1,348,000	327,000
capital expenditures on property, plant and equipment																																												-24,246,000	-21,690,000	-29,658,000	-33,787,000	-37,085,000	-29,927,000	-15,519,000	-15,110,000	-13,092,000	-12,503,000	-15,253,000			-16,239,000	-13,116,000	-12,042,000	-11,801,000	-11,683,000	-10,898,000	-8,864,000	-15,224,000	-11,428,000	-11,996,000	-11,676,000	-21,204,000													-6,476,000
purchased in process research and development
decrease in accounts receivable																																															2,227,000	7,918,000	-14,278,000	11,743,000	-5,411,000	14,100,000				8,020,000				7,939,000	-3,680,000	597,000	-1,492,000	655,000	181,000	2,397,000	564,000	1,222,000
increase in inventories																																															-3,616,000	-9,569,000	11,943,000	-5,289,000	-6,493,000	-12,845,000	-5,953,000	-9,284,000	13,592,000	-17,040,000		-7,657,000	-5,102,000	-10,288,000																					-4,440,000
decrease in prepaid income taxes																																																						524,000	-1,742,000	-455,000	-11,891,000	2,666,000	4,290,000	7,993,000	-8,889,000	3,720,000	232,000	6,617,000	1,802,000	-455,000	-830,000	6,737,000							37,000
decrease in other assets and other long-term liabilities																																																				6,110,000					4,030,000			-3,059,000	-4,486,000	7,743,000	864,000	-4,591,000				-3,633,000
increase in accounts payable and accrued expenses																																																	18,344,000					9,742,000											15,663,000	-2,918,000	1,626,000	-9,108,000	13,187,000	-2,717,000	2,817,000	6,817,000					5,346,000	1,407,000			3,075,000
acquisition of whole blood business																																																					-31,000	0
other acquisitions
excess tax benefit on exercise of stock options																																																	319,000	495,000	621,000	960,000	943,000	1,079,000	968,000	1,111,000	594,000	506,000	20,000	313,000	1,962,000	534,000	79,000	549,000	241,000	23,000	1,000	156,000	1,364,000	687,000	4,137,000	1,282,000	570,000
share repurchase																																																									0	0			0	0	0	-50,000,000		-33,669,000
net increase in cash and cash equivalents																																																				-12,792,000		6,130,000	-48,996,000	7,186,000	23,489,000			20,184,000	27,169,000	54,489,000	31,582,000	-58,095,000	-27,431,000	-9,329,000	4,500,000	17,101,000									9,364,000	21,316,000	19,370,000	11,914,000	12,252,000
purchase of in-process r&d																																																		0
increase in prepaid income taxes																																															-1,715,000	-313,000		-665,000	3,268,000	-4,727,000
increase in other assets and other liabilities																																															-7,571,000	-589,000
net decrease in cash and cash equivalents																																															-9,972,000	-52,526,000		18,698,000
decrease in accounts payable and accrued expenses																																																-5,695,000			-6,404,000	-7,377,000				-9,605,000		-129,000	5,841,000	-7,900,000		-9,136,000	-3,065,000	-19,078,000									3,883,000
transfers from inventory to fixed assets for placements of haemonetics equipment																																																2,443,000		1,933,000	2,677,000	3,357,000		8,439,000	3,931,000	7,236,000		4,620,000	3,142,000	3,150,000		198,000	2,619,000	1,091,000	1,014,000	1,309,000	785,000	2,024,000	644,000	1,190,000	3,991,000	993,000	1,473,000	218,000	602,000	618,000	1,382,000	200,000	150,000	1,234,000	502,000
asset write downs and loss on sale of property, plant and equipment
decrease in other assets and other liabilities																																																		152,000
term loan borrowing
interest expense on contingent consideration																																																			189,000	121,000
non cash items:
unrealized income from hedging activities
contingent consideration income																																																									0	0			0	0
reversal of interest expense on contingent consideration																																																										0
increase in accounts receivable																																																					-5,915,000	-9,479,000				-129,000																							-5,618,000
(increase)/decrease in prepaid income taxes
(increase)/decrease in other assets and other long-term liabilities
(decrease)/increase in accounts payable and accrued expenses
acquisition of global med technologies																																																													0
acquisition of accs																																																													0
investment in hemerus																																																					0	0	0	-1,000,000
net (decrease)/increase in short-term loans
net (decrease)/increase in cash and cash equivalents
loss on sales of property, plant and equipment																																																						254,000	108,000	110,000	492,000	2,000	222,000	56,000	555,000	-197,000	331,000	-15,000
increase in other assets and other long-term liabilities																																																								-5,479,000										1,332,000
deferred tax
term loan
net cash provided/(used) in financing activities
accretion of interest expense on contingent consideration income
purchase of property, plant and equipment																																																								-8,441,000
cash and cash equivalents at beginning of the period																																																								228,861,000
cash and cash equivalents at end of the period																																																								236,047,000
(reversal)/accretion of interest expense on contingent consideration																																																													0	77,000
asset impairment
decrease in inventories																																																													-2,433,000	3,773,000	267,000	-4,167,000		-1,774,000	1,446,000	625,000
acquisition of sebra																																																																	0	0
acquisition of neoteric																																																																	0	0	0	-6,613,000
acquisition of medicell																																																																	1,000	0	0	-307,000
transfers from inventory to fixed assets for placements of
haemonetics equipment
debt assumed from acquisition
employee stock purchase plan																																																											-2,000	1,849,000	-2,000	2,038,000	0	1,645,000	0	1,425,000	27,000	1,457,000	0	1,263,000	0	1,396,000	1,120,000	-8,000	925,000	0	1,012,000	0	816,000	0	680,000
exercise of stock options																																																											2,032,000	2,675,000	8,733,000	26,322,000	2,831,000	3,010,000	12,192,000	1,690,000	2,479,000	909,000	5,107,000	2,701,000	12,819,000	4,779,000	7,607,000				3,785,000	5,504,000	2,509,000	3,260,000	3,841,000
accretion of interest expense on contingent consideration																																																												89,000				165,000		223,000	208,000	200,000
tax benefit on exercise of stock options																																																												356,000
acquisition of altivation
accretion of intererst expense on contingent consideration
acquisition of haemoscope
acquisition of infonale
net decrease in short-term revolving credit agreements
stock repurchase
loss on sales of plant, property and equipment																																																																		149,000	48,000	99,000		-960,000
net increase in short-term revolving credit agreements																																																																		17,000	-2,927,000	16,505,000			-1,078,000	3,178,000									179,000
in-process research and development and cost to equity
acquisition of information data management
acquisition of arryx, inc.
software development company milestone payments
payments on long-term credit agreements
net cash provided by operating activities																																																																						30,881,000	27,935,000	13,842,000							36,865,000
acquisition of infonale, inc.
gain on sales of plant, property and equipment																																																																								1,352,000									-641,000
(increase) in accounts receivable
(increase) in inventories
(increase) in prepaid income taxes
(increase) in other assets and other long-term liabilities
net (decrease) in short-term revolving credit agreements
adjustments to reconcile net income to net cash provided by operating activities:
tax benefit related to exercise of stock options																																																																														1,088,000	734,000	661,000	481,000
unrealized (gain) / loss from hedging activities
decrease / (increase) in accounts receivable
(increase) decrease in inventories
decrease / (increase) in prepaid income taxes
(increase) / decrease in other assets and other long-term liabilities
decrease / (increase) in accounts payable and accrued expenses
purchases of short-term investments
gross proceeds from sale of short-term investments
acquisition of patents
acquisition of licensing rights
investment in preferred stock
net cash (used in) / provided by investing activities
net increase / (decrease) in short-term revolving credit agreements
grant monies received																																																																														0	78,000	-29,000	347,000
net cash (used in) / provided by financing activities
in-process research and development and other
impairment of intangibles
acquisition of software development company and milestone payments
acquisition of license rights
exercise of stock options and related excess tax benefit
in-process research and development/other unusual charges
other assets and other long-term liabilities
acquisition of arryx, inc., net of acquired cash
exercise of stock options and related excess tax benefits
unrealized loss from foreign exchange activities
net increase (decrease) in short-term revolving credit agreements																																																																															-1,035,000
net cash provided by financing activities																																																																															-3,503,000
decrease (increase) in prepaid income taxes																																																																																-55,000	274,000
(decrease) increase in accounts payable and accrued expenses
decrease (increase) in other assets and other long-term liabilities																																																																																	661,000

Haemonetics Corporation(NYSE:HAE)

Haemonetics Corporation
(NYSE:HAE)